WO2016140421A1 - Microcapsule containing structure in which active material is inserted into de-differentiated plant protoplast, and cosmetic composition containing same - Google Patents

Microcapsule containing structure in which active material is inserted into de-differentiated plant protoplast, and cosmetic composition containing same Download PDF

Info

Publication number
WO2016140421A1
WO2016140421A1 PCT/KR2015/012038 KR2015012038W WO2016140421A1 WO 2016140421 A1 WO2016140421 A1 WO 2016140421A1 KR 2015012038 W KR2015012038 W KR 2015012038W WO 2016140421 A1 WO2016140421 A1 WO 2016140421A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
microcapsules
plant
formulation
microcapsule
Prior art date
Application number
PCT/KR2015/012038
Other languages
French (fr)
Korean (ko)
Inventor
김미진
심성보
홍우진
함수진
Original Assignee
코웨이 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코웨이 주식회사 filed Critical 코웨이 주식회사
Publication of WO2016140421A1 publication Critical patent/WO2016140421A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]

Definitions

  • the present invention can maintain stability without breaking by the physical force applied when the active material is incorporated into the de-differentiated plant protoplast in the preparation of a surfactant or cosmetic formulation in order to increase the stability and efficacy of the active material
  • the present invention relates to a microcapsule encapsulated in a microcapsule, a preparation method thereof, and a cosmetic composition containing the same.
  • phytochemicals inherent in natural plants, and they are made up of a myriad of species, including terpenoids, flavonoids, flavonols, polyphenols, amino acids, lignans, alkaloids, vitamins and catechin compounds. .
  • Japanese Laid-Open Patent Publication No. 2012-102136 proposes a cosmetic composition comprising a freeze dried product of dedifferentiated plant cells of a basophilic plant, such as Criste Marine, for skin bleaching and lightening.
  • liposomes using phospholipids or surfactants have been made to apply liposomes using phospholipids or surfactants to the active substance, stabilized cerasomes using ceramides, liquid crystals stabilized with liquid crystal structures, and cubic cubosomes using monoglycerides.
  • International Patent WO2012-173458 discloses a cosmetic composition containing plant cells stabilized with active substances such as gallic acid, amino acids, etc., wherein the plant cells are cell walls, and the active substances are introduced into the cell walls. In this case, it was suggested that the stability of the active substance can be increased.
  • the cell wall of the plant cell contains excess cellulose, which is not easy to penetrate other substances, so it needs to be removed for the entry of the active substance, and if the cell wall and the cell membrane are removed, the stability of the introduced active substance is rather deteriorated. Can be. Accordingly, the present inventors have proposed a structure in which the active material is introduced into a protoplast composed of cell membranes and cell bodies and removed cell walls of plant cells through patent application 10-2013-0164701.
  • the present invention also provides a method for stabilizing a structure by pressure stirring and mixing the structure with vegetable oil to stabilize the structure in which the active substance is introduced into the dedifferentiated plant protoplasm even in an emulsion formulation having a high content of surfactant. It was proposed through patent application No. 10-2014-0173575.
  • the present inventors have conducted various studies so that the structure into which the active substance is introduced into the dedifferentiated plant protoplasm can be maintained without being destroyed by the physical force applied when preparing the surfactant or cosmetic formulation.
  • the encapsulated inside is microencapsulated, the structure was stabilized to confirm that the present invention can be applied in various formulations.
  • an object of the present invention is to provide a microcapsule containing a structure containing an active substance in a dedifferentiated plant protoplast and a cosmetic composition containing the same.
  • a core comprising a structure having an active substance introduced therein into a dedifferentiated plant protoplast
  • microcapsule formed surrounding the core and comprising a shell comprising collagen, acacia gum, lecithin and a crosslinking agent.
  • microcapsules of the present invention can maintain stability not only in nonionic surfactants but also in ionic surfactant-containing formulations, where physical forces are applied during manufacture. Accordingly, the microcapsules in which the structure is encapsulated can be applied to various formulations regardless of the presence or absence, type, content, surfactant, and viscosity of the surfactant. In addition, lecithin contained in the shell of the microcapsules can improve the skin absorption of the supported structure, thereby enhancing the skin improving effect of the active substance introduced into the structure.
  • Example 1 is a photograph of the microcapsules of Example 5 observed 400 times under a microscope.
  • Figure 2 is a graph showing the results of measuring the moisturizing power of using the cosmetic composition of Comparative Formulation Example 6 and Formulation Example 9.
  • Figure 3 is a graph showing the results of measuring the skin elasticity using the cosmetic composition of Comparative Formulation Example 6 and Formulation Example 9.
  • Figure 4 is a graph showing the results of measuring the skin gloss according to the use of the cosmetic composition of Comparative Formulation Example 6 and Formulation Example 9.
  • the present invention provides a method for stabilizing a structure such that the structure in which the active material is introduced into the dedifferentiated plant protoplast can maintain stability even in a manufacturing environment in which a surfactant or a physical force is applied.
  • Protoplasts are protoplasts in which cell walls of cells are removed and cell membranes are present, and various active substances that can be used as cosmetic compositions can be introduced into the cell membranes.
  • the cell wall contains an excess of cellulose, which is not easy to penetrate other materials, so it needs to be removed for the introduction of the active material, and if the cell wall and the cell membrane are removed, the stability of the introduced active material may be lowered. Therefore, protoplasts with cell membranes are preferred.
  • the active substance may be a hydrophilic substance or a hydrophobic substance, and is not particularly limited in the present invention.
  • Representative examples of the active substance include organic acids, vitamins, arbutin, adenosine, niacinamide, polyphenols, flavonoids, retinol, cyclohexanediol bisethylhexanoate, bisretinamido methylpentane, betarapach, growth factor, growth One kind selected from the group consisting of factor complex peptides, and combinations thereof is possible.
  • the active substance is itself used as an active ingredient of the cosmetic composition, it is not stable enough to express its activity, but it is incorporated into the protoplast, thereby increasing the stability of the activity, and the biocompatibility is also greatly improved due to the protoplast. There is an advantage.
  • the structure in which the active substance is introduced into the dedifferentiated plant protoplast according to the present invention can be prepared by the following steps:
  • step (a) the cells of the plant are obtained from the leaves, stems, roots, flowers, berries and seeds of the plant.
  • Plant cell harvesting is not particularly limited in the present invention, and known methods can be used.
  • the plant cells were obtained by dipping into the aqueous solution of sodium chlorate added with a surfactant and then washing.
  • curry plant Helichrysum
  • Commiphora wightii Commiphora myrrha
  • Prickly Pear Cactus Opuntia Ficus indica
  • Peony Paeonia lactiflora
  • Petrifying Adenium) obesum
  • Nymphaea coerulea Eucalyptus punctata , Ginkgo biloba , Lilium candidum , Olive tree ( Olea) europaea
  • papyrus Cyperus papyrus
  • lotus Nelumbo nucifera
  • redwood Sequoia sempervirens
  • rosacea rose Rosa gallica officinalis
  • coffee tree Coffea arabica , Plumeria obtusa , Gardenia jasminoides , Bougainvillea spectabilis
  • step (b) the obtained plant cells are dedifferentiated using auxin to obtain dedifferentiated plant cells.
  • auxin which is used for dedifferentiation, is one of the plant growth regulators, which promotes cell elongation at low concentrations but inhibits growth at high concentrations.
  • the auxin one species selected from the group consisting of alpha-naphtalene acetic acid, 2,4-dichlorophenoxy acetic acid, indole-3-acetic acid, and combinations thereof It is possible to induce dedifferentiation of the plant cells by culturing the plant cells in a medium containing them at a concentration of 1 to 5 mg / l.
  • the medium is not particularly limited in the present invention, any medium used for plant cell culture may be used.
  • step (c) the dedifferentiated plant cells obtained in step (b) are cultured in large quantities.
  • Mass cultivation of dedifferentiated plant cells is carried out in a variety of media, wherein as the medium may be a known medium such as MS medium, B5 medium, WHITE medium, N6 medium, SH medium, Anderson medium, preferably MS Use the medium.
  • the medium may be a known medium such as MS medium, B5 medium, WHITE medium, N6 medium, SH medium, Anderson medium, preferably MS Use the medium.
  • culture conditions and period are not particularly mentioned in the present invention, it can be carried out under the conditions as known.
  • step (d) the cell walls of the largely cultured dedifferentiated plant cells are removed using an enzymatic reaction to obtain a protoplast remaining only in the cell membrane and organelles.
  • the enzyme consists of cellulase (EC 3.2.1.4), pectinase (EC 3.2.1.15), xylanase (EC 3.2.1.8), chitinase (EC 3.2.1.14), hemicellulase and combinations thereof
  • cellulase EC 3.2.1.4
  • pectinase EC 3.2.1.15
  • xylanase EC 3.2.1.8
  • chitinase EC 3.2.1.14
  • hemicellulase hemicellulase
  • These enzymes can be used in various concentrations of 0.01 to 10% by weight, preferably 0.1 to 5% by weight of cellulase, 0.01 to 2.5% by weight of pectinase, 0.1 to 5% by weight of hemicellulase, more preferably A multicomponent enzyme mixture of 1% by weight cellulase, 2% by weight hemicellulase and 0.5% by weight pectinase is used.
  • the enzymatic reaction is carried out in a temperature range of 4 ° C. to 40 ° C. (more preferably 10 ° C. to 25 ° C.) at a rate of 10 to 50 rpm for 15 hours to 24 hours. Only the cell wall is removed and the cell membrane can be stably preserved.
  • step (e) the active material is introduced into the obtained dedifferentiated plant protoplasm by a pressure osmotic process.
  • the dedifferentiated plant protoplasts are dissolved in lower alcohols (C1 to C4 alcohols), mixed with the active substance and water, and sodium chloride is added, the active substance is introduced into the protoplasm by osmosis. do.
  • This process is carried out in a pressurized osmosis process, specifically, at 0.01 to 10 MPa, preferably at 0.05 to 1 MPa, most preferably at 0.05 to 0.5 MPa, wherein the concentration is at least 1% by weight, preferably by addition of sodium chloride. It is made to be 1-50 weight% below. If the pressure and concentration are less than the above range, the introduction of the active substance does not occur effectively. If the pressure and the concentration are above the above range, the protoplasm may be destroyed. Therefore, it is suitably used within the above range.
  • the pulling is carried out so that the concentration of the active substance can be sufficiently exhibited, which may vary depending on the active substance, but has a pulling rate of 0.001 to 20% (based on weight%).
  • the pulling may further perform a dehydration reaction to increase the pulling rate.
  • step (f) the primary post-treatment yields a structure in which the active substance is introduced into the protoplasm.
  • This primary aftertreatment is a conventional aftertreatment process in which unreacted material (active material not taken in) and salts are removed by centrifugation and washing.
  • the structure in which the active material is introduced into the protoplasm obtained through the above steps is maintained with the stability of the active ingredient existing in the plant cells as it is, and further, the stability of the active material introduced into the cells is high. Efficacy is also improved and can be preferably used as an active ingredient composition of the cosmetic.
  • step (g) the structure obtained through the first post-treatment is mixed with the first vegetable oil and then stabilized by stirring simultaneously with the pressurization.
  • the outer wall of the protoplast structure which is mostly composed of phospholipid, ceramide, cholesterol, and the like, is impregnated with the first vegetable oil and pressurized, thereby inducing a change in solubility and stabilizing.
  • the first vegetable oil may be olive oil, sunflower seed oil, meadowfoam seed oil or argan oil.
  • olive oil is used as refined olive oil or extra virgin olive oil.
  • the structure and the first vegetable oil is preferably mixed in a weight ratio of 1: 1.
  • This pressurized stirring process is specifically performed at 0.01-10 MPa, Preferably it is 0.05-1 MPa, Most preferably, it is 0.05-0.5 MPa. If the pressure is less than the above range, the stabilizing effect of the structure is insignificant. If the pressure exceeds the above range, the protoplasm may be destroyed. Therefore, the pressure is suitably performed within the above range.
  • step (h) pressure treatment with the first vegetable oil is carried out through secondary workup to obtain a stabilized structure.
  • This second workup removes the first vegetable oil through centrifugation and washing.
  • step (i) the stabilized structure obtained through the secondary workup is again mixed with the second vegetable oil to obtain a mixture.
  • the second vegetable oil may include avocado oil, wheat germ oil, rosehip oil, almond oil, castor oil, camellia oil, corn, in addition to olive oil, sunflower seed oil, meadowfoam seed oil, or argan oil used as the first vegetable oil.
  • Oil, safflower oil, soybean oil, rape oil, macadamia nut oil, jojoba oil, palm oil, palm kernel oil, coconut oil, mango butter oil, shea butter oil, cocoa seed butter oil, refined grape seed oil, rosehip oil, Sapflower oil or peach seed oil are possible.
  • the stabilized structure and the second vegetable oil obtained through the second post-treatment are preferably mixed in a weight ratio of 1: 9 to 5: 5.
  • steps (g) to (i) may be selectively performed.
  • the structure thus obtained is microencapsulated.
  • the microcapsules of the present invention have a core-shell structure, a core including a structure having an active substance introduced therein into a dedifferentiated plant protoplast, and formed to surround the core, and collagen, acacia gum, and lecithin. And a shell comprising a crosslinking agent.
  • the microcapsules may have a particle size of 10 ⁇ 100 ⁇ m.
  • Collagen, acacia gum, lecithin and crosslinking agents included in the shell may form a wall of microcapsules to stabilize the structure core from an external environment such as a surfactant or a physical force.
  • the crosslinking agent that can be used in the present invention is a substance capable of forming a network by reacting with an amine, for example, selected from the group consisting of glutaaldehyde, glyoxal, and genipin. Can be used.
  • microcapsules according to the present invention can be prepared through coacervation technology, which is a technique for agglomerating cationic polymers and anionic polymers by ion-ion bonding. That is, a capsule was prepared by aggregating by ionic bonding of collagen, a cationic polymer, and acacia gum, an anionic polymer.
  • the present invention provides a cosmetic composition in which the microcapsules are contained in the cosmetic composition to stabilize the plant protoplast structure.
  • the microcapsules may be contained in an amount of 0.001 to 99.0% by weight, preferably 0.01 to 10.0% by weight, more preferably 0.1 to 3% by weight, based on the total weight of the cosmetic composition.
  • microcapsules of the present invention can be prepared in cosmetic formulations of any formulation as is known, and can be used as a lotion, nourishing lotion, nourishing cream, massage cream, essence, pack, paste, gel, cream, lotion, powder, soap, oil, It can be formulated in the form of a foundation, wax or spray.
  • compositions of each formulation may contain various bases and additives necessary and appropriate for the formulation of the formulation, and nonionic surfactants, silicone polymers, extender pigments, fragrances, preservatives, Fungicides, oxidation stabilizers, organic solvents, ionic or nonionic thickeners, softeners, antioxidants, free radical destroying agents, opacifying agents, stabilizers, emollients, silicones, ⁇ -hydroxy acids, antifoams, humectants, And known compounds such as vitamins, insect repellents, fragrances, preservatives, surfactants, anti-inflammatory agents, substance P antagonists, fillers, polymers, propellants, basicizing or acidifying agents, or coloring agents.
  • the formulation of the present invention is a paste, cream or gel, animal oils, vegetable oils, waxes, paraffins, starches, trachants, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide may be used as carrier components.
  • animal oils, vegetable oils, waxes, paraffins, starches, trachants, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide may be used as carrier components.
  • animal oils vegetable oils, waxes, paraffins, starches, trachants, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide
  • cellulose derivatives polyethylene glycols
  • silicones bentonites
  • silicas talc or zinc oxide
  • lactose When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, and especially in the case of spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
  • a solvent, solubilizer or emulsifier is used as the carrier component, such as water, ethanol, isopropanol, ethylcarbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
  • liquid carrier diluents such as water, ethanol or propylene glycol
  • suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Soluble cellulose, aluminum metahydroxide, bentonite, agar or tracant and the like can be used.
  • the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, isethionate, an imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide.
  • Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
  • the tissues are soaked in 70% ethanol (Ethanol, Sigma, USA) for 60 seconds and 30% hydrogen peroxide (LG Chemical, Korea) for 15 minutes and the solvent is removed. Rinse 3 to 5 times with 2 O, soak for 15 minutes in sodium chlorate (Sigma, USA) to which a few drops of Tween 20 was added, and wash 3 to 5 times with sterile H 2 O.
  • tissue culture For tissue culture, these tissue fragments are placed in a sterile Petri dish (125 mm) and cut (2-3 mm) and carefully removed the bleached portion, and the sample thus obtained is thinly cut to give a solid culture medium (see table below). 1) smeared and half buried.
  • Two to three cell clusters (1 to 2 cm) were collected with a spatula, and then plated and dispersed in fresh medium. All this was done on a sterile workbench under sterile conditions.
  • the dedifferentiated plant cells were transferred to the liquid culture medium of Table 2 below, and then cultured in a rotary stirrer at 50 ° C. to 150 rpm under 25 ° C. and dark conditions, and their passage culture period was fixed every 10 days.
  • a multicomponent enzyme mixture (1 wt% of cellulase, 2 wt% of hemicellulase and 0.5 wt% of pectinase) was added to the liquid culture medium in which the dedifferentiated plant cells were grown, and the rate of 50 rpm for 20 hours at a temperature range of 25 ° C. The cell wall was removed.
  • the protoplasts in the culture were obtained by centrifugation for 15 minutes under 200xg, and further purified by centrifugation for 15 minutes under 5,000xg.
  • Oligopeptide-34, Caregen, Korea, Oligopeptide-24, Caregen, Korea, Decapeptide-4, Caregen, Korea, Acetyl Decapeptide -3, Caregen, Korea) and rh-polypeptide-4 (rh-Polypeptide-4, Bio-FD & C, Korea) were added to 4,000 ppm (20,000 ppm total) of tertiary distilled water, respectively, and stirred for 30 minutes.
  • the structure in which the growth factor complex peptide was introduced into the dedifferentiated plant protoplasm obtained in Preparation Example 1 was mixed with extra virgin olive oil in a weight ratio of 1: 1. The mixture was stirred for 24 hours under pressure to 0.5 MPa.
  • Stabilized structure stabilized in vegetable oil in Preparation Example 2 was carried out in the same manner except that the re-dispersed extra virgin olive oil to have a weight ratio of 5:95.
  • Stabilized structure stabilized in vegetable oil in Preparation Example 2 was carried out in the same manner except that the re-dispersed extra virgin olive oil to have a weight ratio of 10:90.
  • Stabilized structure extra virgin olive oil stabilized in vegetable oil in Preparation Example 2 except that it was redispersed again to have a weight ratio of 20:80.
  • the resulting structure mixture has a concentration of about 5,000,000 structures / mL.
  • Stabilized structure extra virgin olive oil stabilized in vegetable oil in Preparation Example 2 except that it was redispersed again to have a weight ratio of 30:70.
  • microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 3 and the extra virgin olive oil was used.
  • microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 4 and the extra virgin olive oil was used.
  • microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 5 and the extra virgin olive oil was used.
  • microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 6 and the extra virgin olive oil was used.
  • microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 7 and the extra virgin olive oil was used.
  • microcapsules obtained in Examples 1 to 6 were magnified 400 times under a microscope (OLYMPUS BX51) (software: QCAPTURE) to confirm the microcapsules and the plant protoplasts embedded therein. The results are shown in Figure 1 and Table 3.
  • Example 1 is a photograph of the microcapsules of Example 5 observed 400 times under a microscope.
  • the protoplasm was enclosed in the microcapsules.
  • 0.1g of the microcapsules were dropped onto the slide glass, covered with a cover glass, pressurized with a force of 0.8N, and then oscillated at a rate of 5 cycles / sec to collapse the microcapsules and then leaked to the outside of the capsule.
  • the plaster structure could be confirmed.
  • the aqueous phase and the oil phase were each dispersed and dissolved while being heated to 75 ° C.
  • the mixture was mixed at 3000 rpm for 3 minutes using a homomixer at 75 ° C.
  • tromethamine was added and neutralized using a homomixer at 3500 rpm for 3 minutes.
  • the mixture was cooled to 45 ° C., and then added with additives.
  • the mixture was dispersed evenly and stirred slowly while cooling.
  • Comparative Composition Example 1 comprising a plant protoplast structure dispersed in its own glycerin of Preparation Example 1 is not stable in a non-ionic surfactant-containing formulation, was developed to improve Cosmetic composition comprising the plant protoplast structure dispersed in the oil phase of Preparation Example 6
  • Comparative Examples 2 to 3 is stable in nonionic surfactant-containing formulations, but rapidly decreased in anionic surfactant-containing formulations.
  • the formulation examples 1 to 5 which is a cosmetic composition comprising Example 5 stabilized by encapsulating it in a microcapsule, it was confirmed that it is stable regardless of the type and content of the surfactant.
  • Comparative Formulation Examples 4 to 6 and Formulation Examples 6 to 9 were carried out in accordance with the composition shown in Table 6 by varying the dispersion method in order to determine the effect of stability of the plant protoplast structure by the physical force applied during manufacture.
  • the aqueous phase and the oil phase were each dispersed and dissolved while being heated to 75 ° C.
  • the mixture was mixed at 3000 rpm for 3 minutes using a homomixer at 75 ° C.
  • tromethamine was added and neutralized using a homomixer at 3500 rpm for 3 minutes.
  • the mixture was cooled to 45 ° C., and then added with additives.
  • the mixture was dispersed evenly and stirred slowly while cooling.
  • the dispersion method was changed by paddle / scraper or homo mixing and the physical force applied was adjusted.
  • Comparative Example 4 containing a phytoprotoplast structure dispersed in the oil developed in the prior art of Preparation Example 6 does not significantly affect the stability during manufacturing by applying a weak physical force, but homo mixing (Homo When a little stronger force is applied through mixing, much of the plant protoplasm structure is destroyed.
  • Example 5 stabilized through microcapsules, it was confirmed that the structure is well maintained without breaking even when a strong physical force is applied during manufacture. Accordingly, when the plant protoplast structure was encapsulated and stabilized by microcapsules, it was confirmed that the present invention can be applied to various products having high viscosity and high hardness as well as low viscosity emulsion formulation.
  • the measuring device used a moisture content measuring instrument (Corneometer CM825, Courage + Khazaka, Germany) to measure the moisture capacity by measuring the electrical capacity of the skin according to the moisture content of the skin.
  • CM825, Courage + Khazaka, Germany a moisture content measuring instrument
  • Negative pressure measurement equipment measures skin on the basis of skin change and restorative force according to the inhalation and duration of inhalation time. The higher the elasticity value is, the better the elasticity is.
  • Cutometer MPA 580 (Courage + Khazaka) measures skin elasticity using the principle that the skin is sucked into the probe during the measurement time with continuous sound pressure, and then the music is removed and the skin is returned to its original appearance.
  • a 2 mm diameter probe connected to the instrument is placed in close contact with the skin and measured in a non-invasive way.
  • the unit of measurement is Arbitrary Unit (A.U.). The results are shown in FIG.
  • CD-2500d Skin specular light was measured using CD-2500d (minolta, Japan).
  • the CD-2500d simultaneously measures SCI and SCE through two pulsed xenon arc lamps and displays them on the liquid crystal within 1.5 seconds.
  • the L * (SCI, SCE) corresponding to the cheek area of the face was measured three times and averaged. And SCI value was calculated by subtracting the SCE value. The results are shown in FIG.
  • the formulation containing the microcapsules according to the present invention has better skin moisturizing, skin elasticity, skin brightness and skin gloss improvement effects than the formulation containing the plant protoplast structure itself. This is believed to be because lecithin, which forms the walls of the microcapsules, improves skin absorption of the plant protoplast structure upon skin application.
  • Microcapsules of Example 5 0.5 Lipophilic monostearate 2.0 Cetearyl Alcohol 2.0 Stearic acid 1.5 Polysorbate 60 1.5 Sorbitan stearate 0.6 Hydrogenated Polyisobutene 1.0 Squalane 3.0 Mineral oil 5.0 Cyclomethicone 5.0 Dimethicone 1.0 Tocopherol Acetate 0.5 glycerin 5.0 Betaine 3.0 Triethanolamine 1.0 Xanthan Gum 0.05 incense Quantity antiseptic Quantity Pigment Quantity Distilled water Remaining amount Sum 100.00
  • a flexible lotion was prepared using a known method to have a composition as shown in Table 10 below.
  • Microcapsules of Example 5 0.3 glycerin 5.0 1,3-butylene glycol 3.0 Betaine 1.0 Allantoin 0.1 DL-panthenol 0.3 EDTA-2Na 0.02 Sodium hyaluronate powder 0.05 ethanol 5.0 Octyldodeceth-16 0.2 Polyoxyethylene Cured Castor Oil 0.2 incense Quantity antiseptic Quantity Pigment Quantity Purified water Remaining amount Sum 100.00
  • Example 5 0.5 Glyceryl Stearate SE 1.5 Cetearyl Alcohol 1.0 Shea Butter 1.5 Polysorbate 60 1.3 Sorbitan stearate 0.5 Cured Vegetable Oil 1.0 Mineral oil 5.0 Squalane 3.0 Cyclomethicone 2.0 Dimethicone 0.8 Tocopherol Acetate 0.5 Carbomer 0.12 glycerin 5.0 1,3-butylene glycol 3.0 Sodium hyaluronate powder 0.05 Triethanolamine 0.12 incense Quantity antiseptic Quantity Pigment Quantity Distilled water Remaining amount Sum 100.00
  • Microcapsules of Example 5 0.5 Lipophilic Monostearic Acid Glycerin 1.5 Cetearyl Alcohol 1.5 Stearic acid 1.0 Polysorbate 60 1.5 Sorbitan stearate 0.6 Isostearyl Isosterate 5.0 Squalane 5.0 Mineral oil 35 Dimethicone 0.5 Hydroxyethyl cellulose 0.12 glycerin 6.0 1,3-butylene glycol 3.0 Triethanolamine 0.3 incense Quantity antiseptic Quantity Pigment Quantity Distilled water Remaining amount Sum 100.00
  • Microcapsules of Example 5 0.5 glycerin 6.0 Betaine 5.0 PEG 1500 2.0 Allantoin 0.1 DL-panthenol 0.3 EDTA-2Na 0.02 Hydrogenated Lecithin 0.6 Hydroxyethyl cellulose 0.1 Sodium hyaluronate powder 0.08 Carboxy Vinyl Polymer 0.2 Triethanolamine 0.2 Ceramide 0.2 Octyldodecanol 3.0 Squalane 3.0 Polysorbate 60 0.4 Glyceryl Stearate SE 1.5 incense Quantity antiseptic Quantity Pigment Quantity Distilled water Remaining amount Sum 100.00
  • Microcapsules of Example 5 0.5 Polyvinyl alcohol 15 Cellulose gum 0.15 glycerin 3.0 PEG 1500 2.0 Betaine 2.0 DL-panthenol 0.4 Allantoin 0.1 Triethanolamine 0.2 Nicotinamide 0.5 ethanol 6.0 PEG 40 Cured Castor Oil 0.3 incense Quantity antiseptic Quantity Pigment Quantity Distilled water Remaining amount Sum 100.00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to: a microcapsule in which a structure is supported within a capsule, allowing a structure in which an active material is inserted into de-differentiated plant protoplast to be applied to various formulations, regardless of the presence or absence, type and content of a surfactant, and the hardness and viscosity of a formulation, in order to increase the stability and efficacy of an active ingredient; and a cosmetic composition containing the same.

Description

탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체 함유 마이크로캡슐 및 이를 함유하는 화장료 조성물Structure-containing microcapsules containing active substances in dedifferentiated plant protoplasts and cosmetic compositions containing same
본 발명은 활성 물질의 안정성 및 효능을 높이기 위해 탈분화 식물 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체가 계면활성제나 화장료 제형으로 제조 시 가해지는 물리적인 힘에 의해 파괴되지 않고 안정성을 유지할 수 있도록 마이크로캡슐 내에 봉입한 마이크로캡슐, 이의 제조방법 및 이를 함유하는 화장료 조성물에 관한 것이다.The present invention can maintain stability without breaking by the physical force applied when the active material is incorporated into the de-differentiated plant protoplast in the preparation of a surfactant or cosmetic formulation in order to increase the stability and efficacy of the active material The present invention relates to a microcapsule encapsulated in a microcapsule, a preparation method thereof, and a cosmetic composition containing the same.
천연에 존재하는 식물에는 각기 다른 수많은 활성 물질(phytochemical)이 내재되어 있으며, 그 종류 또한 테르페노이드, 플라보노이드, 플라보놀, 폴리페놀, 아미노산, 리그난, 알칼로이드, 비타민, 카테킨 화합물 등 무수한 종류로 이루어져 있다.There are many different phytochemicals inherent in natural plants, and they are made up of a myriad of species, including terpenoids, flavonoids, flavonols, polyphenols, amino acids, lignans, alkaloids, vitamins and catechin compounds. .
이에 식물에서 특정 성분만을 추출하거나 식물 세포를 이용한 화장료 조성물이 활발히 제시되고 있다.Therefore, cosmetic compositions using only plant extracts or plant specific components have been actively proposed.
일 예로, 국제특허 WO2013-180526호에서는 에델바이스 추출물이 피부 재생을 촉진시켜 화장료로서 이용 가능하고, 국제특허 WO2012-102456호에서는 비단풀 추출물이 주름 개선에 효과적이어서 다양한 화장료로 사용될 수 있음을 언급하고 있다.As an example, International Patent WO2013-180526 mentions that Edelweiss extract can be used as a cosmetic by promoting skin regeneration, and International Patent WO2012-102456 mentions that silk extract can be used in various cosmetics because it is effective in improving wrinkles.
또한, 일본 공개특허 제2012-102136호는 피부 탈색 및 라이트닝을 위해 크리스테마린(Criste Marine)과 같은 호염성 식물의 탈분화 식물 세포의 동결 건조물을 포함하는 화장품 조성을 제시하고 있다.In addition, Japanese Laid-Open Patent Publication No. 2012-102136 proposes a cosmetic composition comprising a freeze dried product of dedifferentiated plant cells of a basophilic plant, such as Criste Marine, for skin bleaching and lightening.
한편, 레티놀 등과 같은 유효 활성 물질은 인체 내 생리학적 특성에 있어서 유용한 기능을 가짐에도 안정성 면에서 자유롭지 못해, 이의 안정성을 높이기 위해 다양한 방법이 제시되고 있다.On the other hand, effective active substances such as retinol, while having a useful function in the physiological characteristics in the human body is not free from the stability, various methods have been proposed to increase their stability.
일 예로, 활성 물질에 인지질 혹은 계면활성제를 이용한 리포좀, 세라마이드를 이용한 안정화된 세라좀, 액정구조로 안정화시킨 액정좀, 모노글리세라이드를 이용한 입방상 큐보좀 적용 등 많은 시도가 이루어지고 있다.For example, many attempts have been made to apply liposomes using phospholipids or surfactants to the active substance, stabilized cerasomes using ceramides, liquid crystals stabilized with liquid crystal structures, and cubic cubosomes using monoglycerides.
이와 더불어 식물 세포를 화장료 조성물에 적용하고자 하는 연구 또한 진행되고 있다.In addition, research is being conducted to apply plant cells to cosmetic compositions.
국제특허 WO2012-173458호는 내부에 갈릭산(Gallic acid), 아미노산 등의 활성물질이 안정화된 식물 세포를 함유하는 화장료 조성물을 제시하고 있으며, 이때 상기 식물 세포는 세포벽으로서, 세포벽 내에 활성 물질을 인입시키는 경우 활성 물질의 안정성이 높아질 수 있음을 제시하였다.International Patent WO2012-173458 discloses a cosmetic composition containing plant cells stabilized with active substances such as gallic acid, amino acids, etc., wherein the plant cells are cell walls, and the active substances are introduced into the cell walls. In this case, it was suggested that the stability of the active substance can be increased.
식물 세포의 세포벽은 과량의 셀룰로오스를 포함하는데, 이로 인해 다른 물질의 침투가 용이하지 않아 활성 물질의 인입을 위해선 제거가 필요하고, 세포벽과 세포막을 모두 제거할 경우 인입된 활성 물질의 안정성이 오히려 저하될 수 있다. 이에 본 발명자들은 기 출원된 특허출원 제10-2013-0164701호를 통해 식물 세포의 세포벽을 제거하고 세포막 및 세포소로 이루어진 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체를 제안한 바 있다.The cell wall of the plant cell contains excess cellulose, which is not easy to penetrate other substances, so it needs to be removed for the entry of the active substance, and if the cell wall and the cell membrane are removed, the stability of the introduced active substance is rather deteriorated. Can be. Accordingly, the present inventors have proposed a structure in which the active material is introduced into a protoplast composed of cell membranes and cell bodies and removed cell walls of plant cells through patent application 10-2013-0164701.
그러나, 상기 특허의 구조체는 수용성 제품 혹은 제형의 수상에는 사용이 용이하나 오일 성분의 함량이 높은 제품과 계면활성제의 함량이 높은 유화제품에서는 안정도가 떨어지는 단점이 있다.이러한 문제점을 해결하여 오일 제형 및 계면활성제가 고함량으로 존재하는 유화 제형에서도 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체를 안정화할 수 있도록 구조체를 식물성 오일에 가압 교반 및 혼합하는 과정을 통해 구조체를 안정화하는 방법을 본 발명자들은 특허출원 제10-2014-0173575호를 통해 제안한 바 있다.However, the structure of the patent is easy to use in water-soluble products or formulations, but the stability of the oil-containing products and the high content of surfactants has a disadvantage of low stability. The present invention also provides a method for stabilizing a structure by pressure stirring and mixing the structure with vegetable oil to stabilize the structure in which the active substance is introduced into the dedifferentiated plant protoplasm even in an emulsion formulation having a high content of surfactant. It was proposed through patent application No. 10-2014-0173575.
이에 본 발명자들은 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체가 계면활성제나 화장료 제형으로 제조 시 가해지는 물리적인 힘에 의해 파괴되지 않고 안정성을 유지할 수 있도록 다각적으로 연구를 수행한 결과, 상기 구조체가 내부에 봉입되도록 마이크로캡슐화 하는 경우 구조체를 안정화하여 다양한 제형으로 적용할 수 있음을 확인하여 본 발명을 완성하였다.Accordingly, the present inventors have conducted various studies so that the structure into which the active substance is introduced into the dedifferentiated plant protoplasm can be maintained without being destroyed by the physical force applied when preparing the surfactant or cosmetic formulation. When the encapsulated inside is microencapsulated, the structure was stabilized to confirm that the present invention can be applied in various formulations.
따라서, 본 발명의 과제는 탈분화 식물 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체를 함유하는 마이크로캡슐 및 이를 함유하는 화장료 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a microcapsule containing a structure containing an active substance in a dedifferentiated plant protoplast and a cosmetic composition containing the same.
상기 목적을 달성하기 위해, 본 발명은 In order to achieve the above object, the present invention
탈분화 식물 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체를 포함하는 코어와,A core comprising a structure having an active substance introduced therein into a dedifferentiated plant protoplast,
상기 코어를 둘러싸도록 형성되며, 콜라겐, 아카시아 검, 레시틴 및 가교제를 포함하는 쉘을 포함하는 마이크로캡슐을 제공한다.Provided is a microcapsule formed surrounding the core and comprising a shell comprising collagen, acacia gum, lecithin and a crosslinking agent.
본 발명의 마이크로캡슐은 비이온성 계면활성제뿐만 아니라 이온성 계면활성제 함유 제형, 제조시 물리적인 힘이 가해지는 환경에서도 안정성을 유지할 수 있다. 이에 따라 계면활성제의 유무, 종류, 함량, 제형의 경도, 점도에 관계 없이 구조체가 봉입된 마이크로캡슐은 다양한 제형으로 적용이 가능하다. 또한 마이크로캡슐의 쉘에 함유된 레시틴은 담지된 구조체의 피부 흡수를 개선하여 구조체 내에 인입된 활성 물질의 피부 개선 효과를 증진할 수 있다.The microcapsules of the present invention can maintain stability not only in nonionic surfactants but also in ionic surfactant-containing formulations, where physical forces are applied during manufacture. Accordingly, the microcapsules in which the structure is encapsulated can be applied to various formulations regardless of the presence or absence, type, content, surfactant, and viscosity of the surfactant. In addition, lecithin contained in the shell of the microcapsules can improve the skin absorption of the supported structure, thereby enhancing the skin improving effect of the active substance introduced into the structure.
도 1은 실시예 5의 마이크로캡슐을 현미경으로 400배 관찰한 사진이다.1 is a photograph of the microcapsules of Example 5 observed 400 times under a microscope.
도 2는 비교제형예 6과 제형예 9의 화장료 조성물을 사용에 따른 보습력을 측정한 결과를 나타낸 그래프이다.Figure 2 is a graph showing the results of measuring the moisturizing power of using the cosmetic composition of Comparative Formulation Example 6 and Formulation Example 9.
도 3은 비교제형예 6과 제형예 9의 화장료 조성물을 사용에 따른 피부 탄력을 측정한 결과를 나타낸 그래프이다.Figure 3 is a graph showing the results of measuring the skin elasticity using the cosmetic composition of Comparative Formulation Example 6 and Formulation Example 9.
도 4는 비교제형예 6과 제형예 9의 화장료 조성물을 사용에 따른 피부 윤기를 측정한 결과를 나타낸 그래프이다.Figure 4 is a graph showing the results of measuring the skin gloss according to the use of the cosmetic composition of Comparative Formulation Example 6 and Formulation Example 9.
이하 본 발명을 더욱 상세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에서는 탈분화 식물 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체가 계면활성제나 물리적 힘이 인가되는 제조 환경에서도 안정도를 유지할 수 있도록 구조체를 안정화 하는 방법을 제시한다. The present invention provides a method for stabilizing a structure such that the structure in which the active material is introduced into the dedifferentiated plant protoplast can maintain stability even in a manufacturing environment in which a surfactant or a physical force is applied.
프로토플라스트(protoplast)는 세포의 세포벽은 제거되고 세포막이 존재하는 원형질체로, 상기 세포막 내부에 화장료 조성으로 사용 가능한 다양한 활성 물질이 인입이 가능하다. 상기 세포벽은 과량의 셀룰로오스를 포함하는데, 이로 인해 다른 물질의 침투가 용이하지 않아 활성 물질의 인입을 위해선 제거가 필요하고, 세포벽과 세포막을 모두 제거할 경우 인입된 활성 물질의 안정성이 오히려 저하될 수 있으므로, 세포막이 존재하는 프로토플라스트가 바람직하다.Protoplasts are protoplasts in which cell walls of cells are removed and cell membranes are present, and various active substances that can be used as cosmetic compositions can be introduced into the cell membranes. The cell wall contains an excess of cellulose, which is not easy to penetrate other materials, so it needs to be removed for the introduction of the active material, and if the cell wall and the cell membrane are removed, the stability of the introduced active material may be lowered. Therefore, protoplasts with cell membranes are preferred.
활성 물질은 친수성 물질 또는 소수성 물질일 수 있으며, 본 발명에서 특별히 한정하지 않는다. 대표적으로, 활성 물질로는 유기산, 비타민, 알부틴, 아데노신, 나이아신아마이드, 폴리페놀, 플라보노이드, 레티놀, 사이클로헥산다이올 비스에틸헥사노에이트, 비스레틴아미도 메틸펜탄, 베타라파촌, 성장인자, 성장인자 복합 펩타이드, 및 이들의 조합으로 이루어진 군에서 선택된 1종이 가능하다.The active substance may be a hydrophilic substance or a hydrophobic substance, and is not particularly limited in the present invention. Representative examples of the active substance include organic acids, vitamins, arbutin, adenosine, niacinamide, polyphenols, flavonoids, retinol, cyclohexanediol bisethylhexanoate, bisretinamido methylpentane, betarapach, growth factor, growth One kind selected from the group consisting of factor complex peptides, and combinations thereof is possible.
이러한 활성 물질은 그 자체로서 화장료 조성물의 유효 성분으로 사용되나, 안정성이 낮아 그 활성을 충분히 발현할 수 없었으나 프로토플라스트 내에 인입되어 활성 안정성이 높아지고, 상기 프로토플라스트로 인해 생체 적합성 또한 크게 향상되는 이점이 있다. Although the active substance is itself used as an active ingredient of the cosmetic composition, it is not stable enough to express its activity, but it is incorporated into the protoplast, thereby increasing the stability of the activity, and the biocompatibility is also greatly improved due to the protoplast. There is an advantage.
본 발명에 따른 탈분화 식물 프로토플라스트 내에 활성 물질이 인입된 구조체는 다음의 단계를 거쳐 제조될 수 있다:The structure in which the active substance is introduced into the dedifferentiated plant protoplast according to the present invention can be prepared by the following steps:
단계 (a): 식물 세포 수득 단계Step (a): Obtaining Plant Cells
단계 (a)에서는 식물의 잎, 줄기, 뿌리, 꽃, 열매 및 씨앗에서 식물의 세포를 수득한다.In step (a), the cells of the plant are obtained from the leaves, stems, roots, flowers, berries and seeds of the plant.
식물 세포 수득은 본 발명에서 특별히 한정하지 않으며, 공지의 방법이 사용될 수 있다. 일 예로, 본 발명의 실시예에서는 멸균 후 계면활성제가 첨가된 염소산나트륨 수용액에 담근 후 세척하여 식물 세포를 얻을 수 있었다.Plant cell harvesting is not particularly limited in the present invention, and known methods can be used. For example, in the embodiment of the present invention, after sterilization, the plant cells were obtained by dipping into the aqueous solution of sodium chlorate added with a surfactant and then washing.
사용 가능한 식물로는 본 발명에서 특별히 한정하지 않으며, 모든 식물이 가능하다. 대표적으로, 커리플랜트(curry plant, Helichrysum italicum), 구갈(Commiphora wightii , Commiphora myrrha), 부채 선인장(Opuntia Ficus indica), 작약(Paeonia lactiflora), 석화(Adenium obesum), 님파이아 오도라타(Nymphaea coerulea), 유칼리투스(Eucalyptus punctata), 은행나무(Ginkgo biloba), 나리꽃(Lilium candidum), 감람나무(Olea europaea), 파피루스(Cyperus papyrus), 연꽃(Nelumbo nucifera), 레드우드(Sequoia sempervirens), 가리카 로즈(Rosa gallica officinalis), 커피나무(Coffea arabica), 플루메리아(Plumeria obtusa), 치자나무(Gardenia jasminoides), 부겐베리아(Bougainvillea spectabilis), 자스민(Jasminum sambac), 로사 센티폴리아(Rosa centifolia), 페퍼 민트(Mentha piperita), 로사 다마스케나(Rosa damascena), 붓꽃(Iris pallida), 포도나무(Vitis vinifera), 백장미(Rosa alba), 일랑일랑(Cananga odorata), 아몬드 나무(Prunus amygdalus dulcis), 사과나무(Malus domestica), 살구나무(Prunus armeniaca), 인삼(Panax ginseng), 블랙베리(Rubus fruticosus), 금영화(Eschscholtzia californica), 병풀(Centella asiatica), 신양벚나무(Prunus cerasus), 하와이 무궁화(Hibiscus rosa sinensis), 주니퍼베리(Juniperus communis), 목화(Gossypium arboreum), 대추야자(Phoenix dactylifera), 생강(Zingiber officinale), 무궁화(Hibiscus syriacus), 푸에라리아투베로사(Pueraria tuberosa), 석류나무(Punica granatum), 붐박스 코스타튬(Bombax costatum), 사프란(Crocus sativus), 살비아(Salvia officinalis), 수련(Nymphaea alba) 및 이들의 조합으로 이루어진 군에서 선택된 1종이 가능하며, 바람직하기로 커리플랜트(curryplant, Helichrysum italicum), 구갈(Commiphora wightii, Commiphora myrrha), 부채 선인장(Opuntia Ficus indica) 등을 사용한다.As a plant which can be used, it does not specifically limit in this invention, All plants are possible. Typically, curry plant ( Helichrysum) italicum ), Commiphora wightii , Commiphora myrrha ), Prickly Pear Cactus ( Opuntia Ficus indica ), Peony ( Paeonia lactiflora ), Petrifying ( Adenium) obesum ), Nymphaea coerulea , Eucalyptus punctata , Ginkgo biloba , Lilium candidum , Olive tree ( Olea) europaea ), papyrus ( Cyperus papyrus ), lotus ( Nelumbo nucifera ), redwood ( Sequoia sempervirens ), rosacea rose ( Rosa gallica officinalis ), coffee tree ( Coffea arabica , Plumeria obtusa , Gardenia jasminoides , Bougainvillea spectabilis , Jasminum sambac , Rosa centifolia , Peppermint ( Mentha piperita ), Rosa damascena , Iris pallida ), Vine ( Vitis vinifera ), white rose ( Rosa alba ), ylang-ylang ( Cananga odorata ), almond tree ( Prunus amygdalus) dulcis ), apple tree ( Malus domestica ), Apricot ( Prunus armeniaca ), Ginseng ( Panax ginseng ), Blackberry ( Rubus fruticosus ), gold film ( Eschscholtzia californica ), Centella ( Centella asiatica), Shin Yang cherry tree (P runus cerasus), Hawaii Hibiscus (Hibiscus rosa sinensis), Juniper berry (Juniperus communis), cotton (Gossypium arboreum ), date palm ( Phoenix dactylifera ), ginger ( Zingiber officinale ), rose of sharon ( Hibiscus syriacus ), Pueraria tuberosa , pomegranate ( Punica) granatum ), boombox costatum ( Bombax costatum ), saffron ( Crocus sativus ), Salvia ( Salvia officinalis ), water lily ( Nymphaea alba ) and combinations thereof. curryplant, Helichrysum italicum ), comiphora wightii , Commiphora myrrha ), Opuntia Ficus indica ), etc.
단계 (b): Step (b): 탈분화Dedifferentiation 단계 step
단계 (b)에서는 상기 수득된 식물 세포를 옥신을 이용하여 탈분화하여 탈분화된 식물 세포를 얻는다.In step (b), the obtained plant cells are dedifferentiated using auxin to obtain dedifferentiated plant cells.
탈분화(dedifferentiation)에 사용하는 옥신(auxin)은 식물의 생장 조절 물질의 하나로, 저농도에서는 세포 신장을 촉진하나 고농도에서는 생장을 억제한다. 이에 옥신으로는 알파-나프탈렌 아세트산(α-Naphtalene acetic acid), 2,4-디클로로페녹시 아세트산, 인돌-3-아세트산(Indole-3-acetic acid), 및 이들의 조합으로 이루어진 군에서 선택된 1종이 가능하며, 이들을 1∼5㎎/ℓ의 농도로 포함하는 배지에 식물 세포를 배양하여 상기 식물 세포의 탈분화를 유도할 수 있다.Auxin, which is used for dedifferentiation, is one of the plant growth regulators, which promotes cell elongation at low concentrations but inhibits growth at high concentrations. As the auxin, one species selected from the group consisting of alpha-naphtalene acetic acid, 2,4-dichlorophenoxy acetic acid, indole-3-acetic acid, and combinations thereof It is possible to induce dedifferentiation of the plant cells by culturing the plant cells in a medium containing them at a concentration of 1 to 5 mg / l.
상기 배지는 본 발명에서 특별히 한정하지 않으며, 식물 세포 배양에 사용되는 모든 배지가 사용될 수 있다.The medium is not particularly limited in the present invention, any medium used for plant cell culture may be used.
단계 (c): Step (c): 탈분화Dedifferentiation 식물 세포의 배양 단계 Culture step of plant cell
단계 (c)에서는 상기 단계 (b)에서 얻어진 탈분화 식물 세포를 대량으로 배양한다.In step (c), the dedifferentiated plant cells obtained in step (b) are cultured in large quantities.
탈분화 식물 세포의 대량 배양은 다양한 배지 내에서 이루어지며, 이때 배지로는 MS 배지, B5 배지, WHITE 배지, N6 배지, SH 배지, Anderson 배지 등 공지된 바의 배지가 사용될 수 있으며, 바람직하기로 MS 배지를 사용한다.Mass cultivation of dedifferentiated plant cells is carried out in a variety of media, wherein as the medium may be a known medium such as MS medium, B5 medium, WHITE medium, N6 medium, SH medium, Anderson medium, preferably MS Use the medium.
또한, 배양 조건 및 기간은 본 발명에서 특별히 언급하지 않으며, 공지된 바의 조건 하에서 수행할 수 있다.In addition, the culture conditions and period are not particularly mentioned in the present invention, it can be carried out under the conditions as known.
단계 (d): 효소 반응을 통한 세포벽 제거 단계Step (d): Cell Wall Removal Through Enzyme Reaction
단계 (d)에서는 대량으로 배양된 탈분화 식물 세포의 세포벽을 효소 반응을 이용하여 제거하여 세포막과 세포소 기관만 남은 프로토플라스트를 얻는다.In step (d), the cell walls of the largely cultured dedifferentiated plant cells are removed using an enzymatic reaction to obtain a protoplast remaining only in the cell membrane and organelles.
상기 효소는 셀룰라아제(EC 3.2.1.4), 펙티나아제(EC 3.2.1.15), 크실라나아제(EC 3.2.1.8), 키티나아제(EC 3.2.1.14), 헤미셀룰라아제 및 이들의 조합으로 이루어진 군에서 선택된 1종이 가능하다.The enzyme consists of cellulase (EC 3.2.1.4), pectinase (EC 3.2.1.15), xylanase (EC 3.2.1.8), chitinase (EC 3.2.1.14), hemicellulase and combinations thereof One species selected from the group is possible.
이들 효소는 0.01∼10 중량%의 다양한 농도로 사용될 수 있으며, 바람직하기로 셀룰라아제 0.1∼5 중량%, 펙티나아제 0.01∼2.5 중량%, 헤미셀룰라아제 0.1∼5 중량%로 사용하고, 더욱 바람직하기로 셀룰라아제 1 중량%, 헤미셀룰라아제 2 중량% 및 펙티나아제 0.5 중량%의 다성분 효소 혼합물을 사용한다.These enzymes can be used in various concentrations of 0.01 to 10% by weight, preferably 0.1 to 5% by weight of cellulase, 0.01 to 2.5% by weight of pectinase, 0.1 to 5% by weight of hemicellulase, more preferably A multicomponent enzyme mixture of 1% by weight cellulase, 2% by weight hemicellulase and 0.5% by weight pectinase is used.
상기 효소 반응은 4℃∼40℃의 온도 범위에서 (더 적절하게는 10℃∼25℃) 15시간∼24시간 동안 10∼50rpm의 속도로 반응시켜 이루어지며, 이러한 효소 반응에 의해 탈분화 식물 세포의 세포벽만이 제거되고 세포막은 안정하게 보존된 프로토플라스트를 얻을 수 있다.The enzymatic reaction is carried out in a temperature range of 4 ° C. to 40 ° C. (more preferably 10 ° C. to 25 ° C.) at a rate of 10 to 50 rpm for 15 hours to 24 hours. Only the cell wall is removed and the cell membrane can be stably preserved.
단계 (e): 가압 삼투 공정에 의한 활성 물질 인입 단계Step (e): drawing of active substance by pressure osmosis process
단계 (e)에서는 상기 얻어진 탈분화 식물 프로토플라스트 내에 가압 삼투 공정으로 활성 물질을 인입한다.In step (e), the active material is introduced into the obtained dedifferentiated plant protoplasm by a pressure osmotic process.
구체적으로, 탈분화 식물 프로토플라스트를 저급 알코올(C1~C4 알코올)에 용해시키고, 이를 활성 물질 및 물과 혼합한 후 염화나트륨을 첨가하게 되면, 삼투화에 의해 상기 활성 물질이 프로토플라스트 내부로 인입된다.Specifically, when the dedifferentiated plant protoplasts are dissolved in lower alcohols (C1 to C4 alcohols), mixed with the active substance and water, and sodium chloride is added, the active substance is introduced into the protoplasm by osmosis. do.
이러한 공정은 가압 삼투 공정으로 진행되며, 구체적으로는 0.01∼10MPa, 바람직하게는 0.05∼1MPa, 가장 바람직하게는 0.05∼0.5MPa에서 수행하며, 이때 염화나트륨의 첨가에 의해 농도를 1 중량% 이상, 바람직하기로 1∼50 중량%가 되도록 한다. 만약, 상기 압력 및 농도가 상기 범위 미만이면 활성 물질의 인입이 효과적으로 일어나지 않으며, 반대로 상기 범위를 초과하면 프로토플라스트가 파괴될 우려가 있으므로, 상기 범위 내에서 적절히 사용한다.This process is carried out in a pressurized osmosis process, specifically, at 0.01 to 10 MPa, preferably at 0.05 to 1 MPa, most preferably at 0.05 to 0.5 MPa, wherein the concentration is at least 1% by weight, preferably by addition of sodium chloride. It is made to be 1-50 weight% below. If the pressure and concentration are less than the above range, the introduction of the active substance does not occur effectively. If the pressure and the concentration are above the above range, the protoplasm may be destroyed. Therefore, it is suitably used within the above range.
상기 인입은 활성 물질의 효능이 충분히 발휘될 수 있는 농도가 되도록 수행하며, 이는 활성 물질에 따라 달라질 수 있으나, 0.001∼20%의 인입률(중량% 기준)을 갖는다. 추가로, 상기 인입은 인입률을 높이기 위해 탈수 반응을 더욱 수행할 수 있다.The pulling is carried out so that the concentration of the active substance can be sufficiently exhibited, which may vary depending on the active substance, but has a pulling rate of 0.001 to 20% (based on weight%). In addition, the pulling may further perform a dehydration reaction to increase the pulling rate.
단계 (f): 1차 후처리 단계Step (f): First Post Processing Step
단계 (f)에서는 1차 후처리를 통해 프로토플라스트 내에 활성 물질이 인입된 구조체를 얻는다.In step (f), the primary post-treatment yields a structure in which the active substance is introduced into the protoplasm.
이러한 1차 후처리는 통상의 후처리 공정으로, 원심 분리 및 세척을 통해 미반응 물질(인입이 되지 않은 활성 물질) 및 염을 제거한다.This primary aftertreatment is a conventional aftertreatment process in which unreacted material (active material not taken in) and salts are removed by centrifugation and washing.
상기 단계를 거쳐 얻어진 프로토플라스트 내에 활성 물질이 인입된 구조체는 기존에 식물 세포가 갖고 있는 활성 성분의 안정성이 그대로 유지되고 추가적으로 세포 내 인입된 활성 물질의 안정성이 높으며, 이에 따라 상기 활성 물질에 의한 효능 또한 향상되어 화장료의 유효 성분 조성으로 바람직하게 사용 가능하다.The structure in which the active material is introduced into the protoplasm obtained through the above steps is maintained with the stability of the active ingredient existing in the plant cells as it is, and further, the stability of the active material introduced into the cells is high. Efficacy is also improved and can be preferably used as an active ingredient composition of the cosmetic.
단계 (g): 제1식물성 오일과 혼합 후 가압 Step (g): pressurization after mixing with the first vegetable oil 교반하는Stirring 단계 step
단계 (g)에서는 1차 후처리를 통해 얻어진 구조체를 제1식물성 오일과 혼합 후 가압과 동시에 교반하여 안정화 한다.In step (g), the structure obtained through the first post-treatment is mixed with the first vegetable oil and then stabilized by stirring simultaneously with the pressurization.
이와 같은 가압 교반 공정을 통해 인지질, 세라마이드, 콜레스테롤 등으로 대부분 이루어진 프로토플라스트 구조체 외벽이 제1식물성 오일에 함침되어 가압되면서 용해도 변화가 유도되어 안정화될 수 있다. Through the pressure stirring process, the outer wall of the protoplast structure, which is mostly composed of phospholipid, ceramide, cholesterol, and the like, is impregnated with the first vegetable oil and pressurized, thereby inducing a change in solubility and stabilizing.
상기 제1식물성 오일은 올리브 오일, 해바라기씨 오일, 메도우폼씨 오일 또는 아르간 오일이 가능하다. 바람직하기로 올리브 오일로 리파인드 올리브오일 또는 엑스트라버진 올리브오일을 사용한다. The first vegetable oil may be olive oil, sunflower seed oil, meadowfoam seed oil or argan oil. Preferably olive oil is used as refined olive oil or extra virgin olive oil.
이때 구조체와 제1식물성 오일은 1:1의 중량비로 혼합되는 것이 바람직하다. At this time, the structure and the first vegetable oil is preferably mixed in a weight ratio of 1: 1.
이러한 가압 교반 공정은, 구체적으로는 0.01∼10MPa, 바람직하게는 0.05∼1MPa, 가장 바람직하게는 0.05∼0.5MPa에서 수행한다. 만약, 압력이 상기 범위 미만이면, 구조체의 안정화 효과가 미미하고, 반대로 상기 범위를 초과하면 프로토플라스트가 파괴될 우려가 있으므로, 상기 범위 내에서 적절히 수행한다.This pressurized stirring process is specifically performed at 0.01-10 MPa, Preferably it is 0.05-1 MPa, Most preferably, it is 0.05-0.5 MPa. If the pressure is less than the above range, the stabilizing effect of the structure is insignificant. If the pressure exceeds the above range, the protoplasm may be destroyed. Therefore, the pressure is suitably performed within the above range.
단계 (h): 2차 후처리 단계Step (h): second post-treatment step
단계 (h)에서는 2차 후처리를 통해 제1식물성 오일과 함께 가압 교반되어 안정화된 구조체를 얻는다. In step (h), pressure treatment with the first vegetable oil is carried out through secondary workup to obtain a stabilized structure.
이러한 2차 후처리는 원심 분리 및 세척을 통해 제1식물성 오일을 제거한다.This second workup removes the first vegetable oil through centrifugation and washing.
단계 (i): 제2식물성 오일과 혼합Step (i): Mixing with Second Vegetable Oil
단계 (i)에서는 2차 후처리를 통해 얻은 안정화된 구조체를 다시 제2식물성 오일과 혼합하여 혼합물을 얻는다. In step (i), the stabilized structure obtained through the secondary workup is again mixed with the second vegetable oil to obtain a mixture.
이때 상기 제2식물성 오일로는 제1식물성 오일로 사용된 올리브 오일, 해바라기씨 오일, 메도우폼씨 오일 또는 아르간 오일 이외에 아보카도 오일, 밀배아오일, 로즈힙 오일, 아몬드 오일, 피마자유, 동백오일, 옥수수오일, 잇꽃 오일, 대두오일, 유채꽃 오일, 마카나디아넛츠 오일, 호호바 오일, 팜오일, 팜핵오일, 코코넛 오일, 망고버터 오일, 쉐어버터 오일, 코코아수씨드 버터 오일, 정제포도씨 오일, 로즈힙 오일, 사플라워 오일 또는 복숭아씨 오일이 가능하다. In this case, the second vegetable oil may include avocado oil, wheat germ oil, rosehip oil, almond oil, castor oil, camellia oil, corn, in addition to olive oil, sunflower seed oil, meadowfoam seed oil, or argan oil used as the first vegetable oil. Oil, safflower oil, soybean oil, rape oil, macadamia nut oil, jojoba oil, palm oil, palm kernel oil, coconut oil, mango butter oil, shea butter oil, cocoa seed butter oil, refined grape seed oil, rosehip oil, Sapflower oil or peach seed oil are possible.
상기 2차 후처리를 통해 얻은 안정화된 구조체와 제2식물성 오일은 1:9 내지 5:5의 중량비로 혼합하는 것이 바람직하다. The stabilized structure and the second vegetable oil obtained through the second post-treatment are preferably mixed in a weight ratio of 1: 9 to 5: 5.
이때 단계 (g) 내지 (i)는 선택적으로 실시할 수 있다. In this case, steps (g) to (i) may be selectively performed.
본 발명에서는 이렇게 얻은 구조체를 마이크로캡슐화한다.In the present invention, the structure thus obtained is microencapsulated.
구체적으로, 본 발명의 마이크로캡슐은 코어-쉘 구조로, 탈분화 식물 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체를 포함하는 코어와, 상기 코어를 둘러싸도록 형성되며, 콜라겐, 아카시아 검, 레시틴 및 가교제를 포함하는 쉘을 포함한다. Specifically, the microcapsules of the present invention have a core-shell structure, a core including a structure having an active substance introduced therein into a dedifferentiated plant protoplast, and formed to surround the core, and collagen, acacia gum, and lecithin. And a shell comprising a crosslinking agent.
이때 마이크로캡슐은 그 입자 크기가 10~100 ㎛일 수 있다. At this time, the microcapsules may have a particle size of 10 ~ 100 ㎛.
상기 쉘에 포함된 콜라겐, 아카시아 검, 레시틴 및 가교제는 마이크로캡슐의 벽제를 형성하여 구조체 코어를 계면활성제, 물리적인 힘 등의 외부 환경으로부터 안정화 시킬 수 있다. Collagen, acacia gum, lecithin and crosslinking agents included in the shell may form a wall of microcapsules to stabilize the structure core from an external environment such as a surfactant or a physical force.
본 발명에서 사용할 수 있는 가교제로는 아민과 반응하여 망상구조를 이룰 수 있는 물질로, 예를 들어 글루타알데하이드(glutaldehyde), 글리옥살(glyoxal), 및 제니핀(genipin)으로 이루어지는 군에서 선택하여 사용할 수 있다. The crosslinking agent that can be used in the present invention is a substance capable of forming a network by reacting with an amine, for example, selected from the group consisting of glutaaldehyde, glyoxal, and genipin. Can be used.
본 발명에 따른 마이크로캡슐은 양이온성 고분자와 음이온성 고분자를 이온-이온 결합에 의해 응집하는 기술인 코아세르베이션(coacervation) 기술을 통해 제조될 수 있다. 즉, 양이온성 고분자인 콜라겐과 음이온성 고분자인 아카시아 검의 이온성 결합에 의해 응집하는 방법을 통해 캡슐을 제조하였다. The microcapsules according to the present invention can be prepared through coacervation technology, which is a technique for agglomerating cationic polymers and anionic polymers by ion-ion bonding. That is, a capsule was prepared by aggregating by ionic bonding of collagen, a cationic polymer, and acacia gum, an anionic polymer.
본 발명은 마이크로 캡슐을 화장료 조성물에 함유하여 식물 프로토플라스트 구조체가 안정화된 화장료 조성물을 제공한다. 상기 마이크로캡슐은 전체 화장료 조성물 총 중량에 대하여 0.001 내지 99.0 중량%, 바람직하게는 0.01 내지 10.0 중량%, 더욱 바람직하게는 0.1 내지 3 중량%로 함유될 수 있다.The present invention provides a cosmetic composition in which the microcapsules are contained in the cosmetic composition to stabilize the plant protoplast structure. The microcapsules may be contained in an amount of 0.001 to 99.0% by weight, preferably 0.01 to 10.0% by weight, more preferably 0.1 to 3% by weight, based on the total weight of the cosmetic composition.
본 발명의 마이크로 캡슐은 공지된 바의 어떠한 제형의 화장품 조성물로 제조될 수 있으며, 화장수, 영양로션, 영양크림, 마사지크림, 에센스, 팩, 페이스트, 겔, 크림, 로션, 파우더, 비누, 오일, 파운데이션, 왁스 또는 스프레이형태로 제형화할 수 있다.The microcapsules of the present invention can be prepared in cosmetic formulations of any formulation as is known, and can be used as a lotion, nourishing lotion, nourishing cream, massage cream, essence, pack, paste, gel, cream, lotion, powder, soap, oil, It can be formulated in the form of a foundation, wax or spray.
또한, 각 제형의 화장료 조성물에 있어서, 상기의 세포 이외에 다른 성분들을 기타 화장료의 제형 또는 사용 목적 등에 따라 임의로 선정하여 배합할 수 있다. 또한, 각 제형의 조성들은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 그 효과를 떨어트리지 않는 범위 내에서 비이온 계면활성제, 실리콘 폴리머, 체질안료, 향료, 방부제, 살균제, 산화 안정화제, 유기 용매, 이온성 또는 비이온성 증점제, 유연화제, 산화방지제, 자유 라디칼 파괴제, 불투명화제, 안정화제, 에몰리언트(emollient), 실리콘, α-히드록시산, 소포제, 보습제, 비타민, 곤충 기피제, 향료, 보존제, 계면활성제, 소염제, 물질 P 길항제, 충전제, 중합체, 추진제, 염기성화 또는 산성화제, 또는 착색제 등 공지의 화합물을 포함하여 제조된다.In addition, in the cosmetic composition of each formulation, other components in addition to the cells described above may be arbitrarily selected and blended according to the formulation or use purpose of other cosmetics. In addition, the compositions of each formulation may contain various bases and additives necessary and appropriate for the formulation of the formulation, and nonionic surfactants, silicone polymers, extender pigments, fragrances, preservatives, Fungicides, oxidation stabilizers, organic solvents, ionic or nonionic thickeners, softeners, antioxidants, free radical destroying agents, opacifying agents, stabilizers, emollients, silicones, α-hydroxy acids, antifoams, humectants, And known compounds such as vitamins, insect repellents, fragrances, preservatives, surfactants, anti-inflammatory agents, substance P antagonists, fillers, polymers, propellants, basicizing or acidifying agents, or coloring agents.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal oils, vegetable oils, waxes, paraffins, starches, trachants, cellulose derivatives, polyethylene glycols, silicones, bentonites, silicas, talc or zinc oxide may be used as carrier components. Can be.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로하이드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, and especially in the case of spray, additionally chlorofluorohydrocarbon, propane Propellant such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as the carrier component, such as water, ethanol, isopropanol, ethylcarbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 Fatty acid esters of, 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타하이드록사이드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, liquid carrier diluents such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystals Soluble cellulose, aluminum metahydroxide, bentonite, agar or tracant and the like can be used.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, isethionate, an imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 더욱 쉽게 이해하기 위하여 제공되는 것일 뿐, 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다. Hereinafter, preferred examples are provided to aid in understanding the present invention. However, the following examples are merely provided to more easily understand the present invention, and the contents of the present invention are not limited by the examples.
제조예Production Example 1 One
(1) (One) 탈분화Dedifferentiation 식물 세포의 수득 Obtain of Plant Cells
커리플랜트(curry plant, Helichrysum italicum), 구갈(Commiphora wightii), 부채 선인장(Opuntia Ficus indica)의 줄기, 잎에서 조직 절편 (최소 3㎝)을 절단하였다. Curry Plant ( Helichrysum italicum ), comiphora wightii), prickly pear cactus ( Opuntia Ficus tissue sections (at least 3 cm) were cut from the stem and leaves of the indica ).
본 조작 단계에서, 모든 작업은 무균 조건하에 무균 작업대에서 수행하였다. In this operating step, all work was performed on a sterile workbench under sterile conditions.
식물 재료를 멸균하기 위하여, 조직은 70% 에탄올(Ethanol, Sigma, USA)에 60초, 30% 과산화수소(Hydrogen peroxide, LG Chemical, Korea)에 15분 담그고 용제를 제거하며, 이후 이들 조직은 무균 H2O로 3∼5회 씻어내고 몇 방울의 Tween 20이 첨가된 염소산나트륨(Sodium hydrochlorite, Sigma, USA)에 15분간 담그고 무균 H2O로 3∼5회 씻어냈다.To sterilize the plant material, the tissues are soaked in 70% ethanol (Ethanol, Sigma, USA) for 60 seconds and 30% hydrogen peroxide (LG Chemical, Korea) for 15 minutes and the solvent is removed. Rinse 3 to 5 times with 2 O, soak for 15 minutes in sodium chlorate (Sigma, USA) to which a few drops of Tween 20 was added, and wash 3 to 5 times with sterile H 2 O.
조직 배양을 위하여, 이들 조직 단편은 무균 페트리 접시(125㎜)에 집어넣고 절단하며 (2∼3㎜) 표백된 부분을 조심스럽게 제거하고, 이렇게 수득된 시료는 가늘게 절개하여 고형 배양 배지(하기 표 1)에 도말하고 반쯤 묻었다.For tissue culture, these tissue fragments are placed in a sterile Petri dish (125 mm) and cut (2-3 mm) and carefully removed the bleached portion, and the sample thus obtained is thinly cut to give a solid culture medium (see table below). 1) smeared and half buried.
원료 Raw material 함량(mg/L)Content (mg / L)
KNO3 KNO 3 2,5002,500
(NH4)2SO4 (NH 4 ) 2 SO 4 134134
CaCl2·2H2OCaCl 2 · 2H 2 O 120120
NaH2PO4·2H2ONaH 2 PO 4 · 2H 2 O 150150
MgSO4·7H2OMgSO 4 7 H 2 O 200200
MnSO4·4H2OMnSO 4 4H 2 O 1515
ZnSO4·7H2OZnSO 4 · 7H 2 O 55
H3BO3 H 3 BO 3 44
KIKI 0.80.8
Na2MoO4·2H2ONa 2 MoO 4 2H 2 O 0.250.25
CuSO4·5H2OCuSO 4 · 5H 2 O 0.0250.025
CoCl2·6H2OCoCl 2 · 6H 2 O 0.0250.025
FeSO4·7H2OFeSO 4 7H 2 O 32.832.8
미요이노시톨(Myo-inositol)Miyo-inositol 200200
니코틴산(Nicotinic acid)Nicotinic acid 22
아스코브산(L-ascorbic acid)L-ascorbic acid 3030
시트르산(Citric acid)Citric acid 5050
비오틴((+)-Biotin)Biotin ((+)-Biotin) 0.010.01
염화피리독신(Pyridoxine-HCl)Pyridoxine-HCl 22
염화티아민(Thiamine-HCl)Thiamine Chloride (Thiamine-HCl) 1010
수크로오스(Sucrose)Sucrose 20,00020,000
알파-나프탈렌 아세트산(α-Naphtalene acetic acid)Alpha-naphtalene acetic acid 22
2,4-디클로로페녹시 아세트산(2,4-dichlorophenoxy acetic acid)2,4-dichlorophenoxy acetic acid 0.50.5
키네틴(Kinetin)Kinetin 0.50.5
아가(Agar)Agar 9,0009,000
정제수Purified water 잔량Remaining amount
(2) (2) 탈분화Dedifferentiation 식물세포의 재식(Replanting) Planting of Plant Cells
압설자(Spatula)로 2∼3개의 세포 클러스터(1∼2cm)를 채취한 후, 새로운 배지에 도말하고 분산시켰다. 이 모든 과정은 무균 조건하에 무균 작업대에서 수행하였다.Two to three cell clusters (1 to 2 cm) were collected with a spatula, and then plated and dispersed in fresh medium. All this was done on a sterile workbench under sterile conditions.
(3) 액상 배양 배지에서 (3) in the liquid culture medium 탈분화Dedifferentiation 식물 세포의 증식 Proliferation of plant cells
상기의 탈분화된 식물 세포를 하기 표 2의 액상 배양 배지로 이전한 다음, 25℃, 암조건 하에서 50∼150rpm의 회전 교반기에서 배양하였으며, 이때 이들의 계대 배양 주기는 매10일로 고정하였다.The dedifferentiated plant cells were transferred to the liquid culture medium of Table 2 below, and then cultured in a rotary stirrer at 50 ° C. to 150 rpm under 25 ° C. and dark conditions, and their passage culture period was fixed every 10 days.
원료Raw material 함량(mg/L)Content (mg / L)
NH4NO3 NH 4 NO 3 400400
Ca(NO3)2 Ca (NO 3 ) 2 500500
CaCl2·2H2OCaCl 2 · 2H 2 O 100100
KH2PO4 KH 2 PO 4 200200
MgSO4·7H2OMgSO 4 7 H 2 O 150150
MnSO4·4H2OMnSO 4 4H 2 O 2020
ZnSO4·7H2OZnSO 4 · 7H 2 O 55
H3BO3 H 3 BO 3 55
K2SO4 K 2 SO 4 1,0001,000
Na2MoO4·2H2ONa 2 MoO 4 2H 2 O 0.250.25
CuSO4·5H2OCuSO 4 · 5H 2 O 0.250.25
FeSO4·7H2OFeSO 4 7H 2 O 32.832.8
미요이노시톨(Myo-inositol)Miyo-inositol 200200
니코틴산(Nicotinic acid)Nicotinic acid 22
아스코브산(L-ascorbic acid)L-ascorbic acid 3030
시트르산(Citric acid)Citric acid 5050
비오틴((+)-Biotin)Biotin ((+)-Biotin) 0.010.01
염화피리독신(Pyridoxine-HCl)Pyridoxine-HCl 22
염화티아민(Thiamine-HCl)Thiamine Chloride (Thiamine-HCl) 1010
수크로오스(Sucrose)Sucrose 30,00030,000
알파-나프탈렌 아세트산(α-Naphtalene acetic acid)Alpha-naphtalene acetic acid 22
2,4-디클로로페녹시 아세트산(2,4-dichlorophenoxy acetic acid)2,4-dichlorophenoxy acetic acid 0.50.5
키네틴(Kinetin)Kinetin 0.50.5
정제수Purified water 잔량Remaining amount
(4) (4) 탈분화Dedifferentiation 식물세포의 세포벽을 제거한  Remove cell wall of plant cell 프로토플라스트Protoplasm 수득 purchase
상기 얻어진 탈분화 식물세포가 증식된 액상 배양 배지에 다성분 효소 혼합물(셀룰라아제 1 wt%, 헤미셀룰라아제 2 wt% 및 펙티나아제 0.5 wt%)을 첨가하고 25℃의 온도 범위에서 20시간 동안 50rpm의 속도로 반응시켜 세포벽을 제거하였다.A multicomponent enzyme mixture (1 wt% of cellulase, 2 wt% of hemicellulase and 0.5 wt% of pectinase) was added to the liquid culture medium in which the dedifferentiated plant cells were grown, and the rate of 50 rpm for 20 hours at a temperature range of 25 ° C. The cell wall was removed.
이어, 배양액 중의 원형질체를 200xg 하에서 15분간 원심분리하여 수득한 후, 다시 5,000xg 하에서 15분간 원심분리하여 추가로 정제하였다.Subsequently, the protoplasts in the culture were obtained by centrifugation for 15 minutes under 200xg, and further purified by centrifugation for 15 minutes under 5,000xg.
(5) (5) 탈분화Dedifferentiation 식물  plant 프로토플라스트Protoplasm 내에 성장인자 복합  Growth factor complex 펩타이드(growth factor mimic peptides)가Growth factor mimic peptides 인입된 구조체의 제조 Preparation of Reinforced Structures
올리고펩타이드-34(Oligopeptide-34, Caregen, Korea), 올리고펩타이드-24(Oligopeptide-24, Caregen, Korea), 데카펩타이드-4(Decapeptide-4, Caregen, Korea), 아세틸 데카펩타이드-3(Acetyl Decapeptide-3, Caregen, Korea) 및 rh-폴리펩타이드-4(rh-Polypeptide-4, Bio-FD&C, Korea)를 3차 증류수에 각각 4,000 ppm(총 20,000ppm)으로 가하여 30분간 교반하였다. Oligopeptide-34, Caregen, Korea, Oligopeptide-24, Caregen, Korea, Decapeptide-4, Caregen, Korea, Acetyl Decapeptide -3, Caregen, Korea) and rh-polypeptide-4 (rh-Polypeptide-4, Bio-FD & C, Korea) were added to 4,000 ppm (20,000 ppm total) of tertiary distilled water, respectively, and stirred for 30 minutes.
얻어진 펩타이드 혼합물 용액 20 중량%에, 상기 제조예 1에서 제조한 프로토플라스트 20 중량%, 및 증류수 60 중량%에 넣고, 패들믹서(PL-S10, Poonglim, Korea)를 이용하여 500rpm, 25℃ 조건으로 1시간 동안 교반하였다.In 20% by weight of the obtained peptide mixture solution, 20% by weight of the protoplast prepared in Preparation Example 1, and 60% by weight of distilled water, and 500rpm, 25 ℃ conditions using a paddle mixer (PL-S10, Poonglim, Korea) Stirred for 1 h.
이어, 펩타이드 혼합물 용액, 프로토플라스트 및 증류수의 혼합액에 염화나트륨(NaCl, Sigma, USA)을 2 중량% 넣고 고압반응기(Miniclave, Buchi AG, Switzerland)를 이용하여 0.5MPa, 25℃ 1시간 조건으로 역삼투, 탈수 및 펩타이드의 인입 반응을 유도했다. 그 후, 원심분리기(Supra 22K, Hanil, Korea)를 이용하여 5,000xg 하에서 20분간 원심분리하여 프로토플라스트 내에 펩타이드가 인입된 구조체를 수득하였다. 이렇게 얻어진 구조체는 보존을 위해 구조체 20 중량%에 글리세린 80 중량%를 가하여 분산액 상태로 보관하였다. Subsequently, 2 wt% of sodium chloride (NaCl, Sigma, USA) was added to the mixture of the peptide mixture solution, the protoplasm and the distilled water, and reverse osmosis was performed at 0.5 MPa and 25 ° C. for 1 hour using a high pressure reactor (Miniclave, Buchi AG, Switzerland). Permeation, dehydration and induction of peptides were induced. Thereafter, centrifugation was performed under a centrifuge (Supra 22K, Hanil, Korea) for 20 minutes at 5,000xg to obtain a structure in which the peptide was introduced into the protoplast. The structure thus obtained was stored in a dispersion state by adding 80% by weight of glycerin to 20% by weight of the structure.
제조예Production Example 2 2
상기 제조예 1에서 얻어진 탈분화 식물 프로토플라스트 내에 성장인자 복합 펩타이드가 인입된 구조체를 엑스트라버진 올리브오일과 1:1의 중량비로 혼합하였다. 이 혼합물을 0.5MPa으로 가압하면서 24시간 동안 교반하였다. The structure in which the growth factor complex peptide was introduced into the dedifferentiated plant protoplasm obtained in Preparation Example 1 was mixed with extra virgin olive oil in a weight ratio of 1: 1. The mixture was stirred for 24 hours under pressure to 0.5 MPa.
그 후, 원심분리기(Supra 22K, Hanil, Korea)를 이용하여 5,000xg 하에서 20분간 원심분리 하여 식물성 오일에 안정화 된 구조체를 수득하고 이를 식물성 오일에 안정화된 구조체: 엑스트라버진 올리브오일이 0.1:99.9의 중량비를 갖도록 다시 재분산하였다. Thereafter, centrifugation (Supra 22K, Hanil, Korea) using a centrifuge at 5,000xg for 20 minutes to obtain a structure stabilized in vegetable oil, which was stabilized in vegetable oil: Extra virgin olive oil of 0.1: 99.9 Redispersed again to have a weight ratio.
제조예Production Example 3 3
상기 제조예 2에서 식물성 오일에 안정화된 안정화된 구조체: 엑스트라버진 올리브오일이 5:95의 중량비를 갖도록 다시 재분산한 것을 제외하고 동일하게 실시하였다.Stabilized structure stabilized in vegetable oil in Preparation Example 2 was carried out in the same manner except that the re-dispersed extra virgin olive oil to have a weight ratio of 5:95.
제조예Production Example 4 4
상기 제조예 2에서 식물성 오일에 안정화된 안정화된 구조체: 엑스트라버진 올리브오일이 10:90의 중량비를 갖도록 다시 재분산한 것을 제외하고 동일하게 실시하였다.Stabilized structure stabilized in vegetable oil in Preparation Example 2 was carried out in the same manner except that the re-dispersed extra virgin olive oil to have a weight ratio of 10:90.
제조예Production Example 5 5
상기 제조예 2에서 식물성 오일에 안정화된 안정화된 구조체: 엑스트라버진 올리브오일이 15:85의 중량비를 갖도록 다시 재분산한 것을 제외하고 동일하게 실시하였다.Stabilized structure stabilized in vegetable oil in Preparation Example 2, except that the extra virgin olive oil was redispersed again to have a weight ratio of 15:85.
제조예Production Example 6 6
상기 제조예 2에서 식물성 오일에 안정화된 안정화된 구조체: 엑스트라버진 올리브오일이 20:80의 중량비를 갖도록 다시 재분산한 것을 제외하고 동일하게 실시하였다. 이렇게 얻은 구조체 혼합물은 약 5,000,000 구조체/mL의 농도를 갖는다. Stabilized structure: extra virgin olive oil stabilized in vegetable oil in Preparation Example 2 except that it was redispersed again to have a weight ratio of 20:80. The resulting structure mixture has a concentration of about 5,000,000 structures / mL.
제조예Production Example 7 7
상기 제조예 2에서 식물성 오일에 안정화된 안정화된 구조체: 엑스트라버진 올리브오일이 30:70의 중량비를 갖도록 다시 재분산한 것을 제외하고 동일하게 실시하였다.Stabilized structure: extra virgin olive oil stabilized in vegetable oil in Preparation Example 2 except that it was redispersed again to have a weight ratio of 30:70.
실시예Example 1 One
제조예 2에서 얻은 탈분화 식물 프로토플라스트와 엑스트라버진 올리브오일의 분산액 25g, 하이드로제네이티드폴리데센 74g, 레시틴 1g을 10 wt% 콜라겐 수용액 100 g 에 넣고 50℃로 가온하여 유화하였다. 추가로 10 wt% 아라비아 검 수용액 100 g 를 넣고 50℃에서 20 분 동안 혼합하였다. 이후 추가로 온수 150 mL를 넣은 다음 pH 조절제를 적량 넣어 pH를 4로 조정하여 코아세르베이션을 하였다. 이후 10 ℃ 이하로 냉각한 다음 25 wt% 글루타르알데히드 용액 10 g 와 정제수 300 g 를 넣어 상온에서 5 시간 동안 벽제를 가교하였다. pH 조절제를 적량 넣어 pH를 8.5로 조절하여 마이크로캡슐 분산액을 얻었다. 25 g of the dedifferentiated plant protoplasm obtained in Preparation Example 2 and extra virgin olive oil, 74 g of hydrogenated polydecene, and 1 g of lecithin were added to 100 g of a 10 wt% collagen aqueous solution and warmed to 50 ° C. to emulsify. Further 100 g of 10 wt% Arabian gum aqueous solution was added and mixed at 50 ° C. for 20 minutes. Thereafter, 150 mL of hot water was added, and then pH was adjusted to 4 by adding an appropriate amount of a pH regulator to coacervate. After cooling to 10 ° C or less, 10 g of a 25 wt% glutaraldehyde solution and 300 g of purified water were added to crosslink the wall at room temperature for 5 hours. The pH was adjusted to 8.5 to suitably add a pH adjusting agent to obtain a microcapsule dispersion.
실시예Example 2 2
상기 실시예 1에서 제조예 3에서 얻은 탈분화 식물 프로토플라스트와 엑스트라버진 올리브오일의 분산액을 사용한 것을 제외하고 동일하게 수행하여 마이크로캡슐 분산액을 얻었다.The microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 3 and the extra virgin olive oil was used.
실시예Example 3 3
상기 실시예 1에서 제조예 4에서 얻은 탈분화 식물 프로토플라스트와 엑스트라버진 올리브오일의 분산액을 사용한 것을 제외하고 동일하게 수행하여 마이크로캡슐 분산액을 얻었다.The microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 4 and the extra virgin olive oil was used.
실시예Example 4 4
상기 실시예 1에서 제조예 5에서 얻은 탈분화 식물 프로토플라스트와 엑스트라버진 올리브오일의 분산액을 사용한 것을 제외하고 동일하게 수행하여 마이크로캡슐 분산액을 얻었다.The microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 5 and the extra virgin olive oil was used.
실시예Example 5 5
상기 실시예 1에서 제조예 6에서 얻은 탈분화 식물 프로토플라스트와 엑스트라버진 올리브오일의 분산액을 사용한 것을 제외하고 동일하게 수행하여 마이크로캡슐 분산액을 얻었다.The microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 6 and the extra virgin olive oil was used.
실시예Example 6 6
상기 실시예 1에서 제조예 7에서 얻은 탈분화 식물 프로토플라스트와 엑스트라버진 올리브오일의 분산액을 사용한 것을 제외하고 동일하게 수행하여 마이크로캡슐 분산액을 얻었다.The microcapsule dispersion was obtained in the same manner as in Example 1 except that the dispersion of the dedifferentiated plant protoplasm obtained in Preparation Example 7 and the extra virgin olive oil was used.
실험예Experimental Example 1:  One: 탈분화Dedifferentiation 식물  plant 프로트플라스트Proteplast 함량에 따른 봉입 상태 확인 Check the filling status according to the content
실시예 1 내지 6에서 얻은 마이크로캡슐을 현미경(OLYMPUS BX51)(소프트웨어:QCAPTURE)으로 400배 확대 관찰하여 마이크로캡슐 및 그 내에 함입된 식물 프로토플라스트를 확인하였다. 그 결과는 도 1 및 표 3에 나타내었다. The microcapsules obtained in Examples 1 to 6 were magnified 400 times under a microscope (OLYMPUS BX51) (software: QCAPTURE) to confirm the microcapsules and the plant protoplasts embedded therein. The results are shown in Figure 1 and Table 3.
구분division 실시예1Example 1 실시예2Example 2 실시예3Example 3 실시예4Example 4 실시예5Example 5 실시예6Example 6
분산액 중 식물 프로토플라스트 함량(wt%)Plant Protoplast Content in Dispersion (wt%) 0.10.1 55 1010 1515 2020 3030
봉입 상태Enclosed state
이때 ◎은 "아주 좋음", ○는 "양호", △는 "약간 이상하나 실용상으로 문제가 없음", ×는 "불안정"을 의미한다.◎ is "very good", ○ is "good", △ is "slightly strange but practically no problem", × means "unstable".
도 1은 실시예 5의 마이크로캡슐을 현미경으로 400배 관찰한 사진이다.1 is a photograph of the microcapsules of Example 5 observed 400 times under a microscope.
도 1을 참조하면 마이크로캡슐 내부에 프로토플라스트가 봉입되어 있음을 확인할 수 있었다. 마이크로캡슐 0.1g을 슬라이드 글라스에 떨어뜨린 후 커버 글라스를 덮어준 후 0.8N의 힘으로 압력을 가한 후 5cycle/sec의 속도로 진동(oscillation)시켜 마이크로캡슐을 붕괴시킨 후 캡슐 외부로 유출된 프로프플라스트 구조체를 확인할 수 있었다.Referring to FIG. 1, it was confirmed that the protoplasm was enclosed in the microcapsules. 0.1g of the microcapsules were dropped onto the slide glass, covered with a cover glass, pressurized with a force of 0.8N, and then oscillated at a rate of 5 cycles / sec to collapse the microcapsules and then leaked to the outside of the capsule. The plaster structure could be confirmed.
실험예 2: 계면활성제 종류에 따른 식물 프로토플라스트 구조체 안정도 영향 확인 Experimental Example 2: Checking the effect of stability of plant protoplast structure according to the type of surfactant
하기 표 4에 기재된 조성에 따라 제형예 1 내지 5 및 비교제형예 1 내지 3의 화장료 조성물을 제조하였다.To the cosmetic composition of Formulation Examples 1 to 5 and Comparative Formulation Examples 1 to 3 according to the composition shown in Table 4.
먼저, 수상, 유상을 각각 75 ℃로 가온하며 분산, 용해시켰다. 수상 파트와 유상 파트가 준비되면 75 ℃에서 호모믹서를 이용하여 3분간 3000rpm으로 섞어주었다. 그 후 트로메타민을 넣어 3분간 3500rpm으로 호모믹서를 이용하여 중화하고 45℃로 냉각하여 첨가물을 넣어준 후 골고루 분산시켜준 후 냉각하면서 천천히 저어주었다.First, the aqueous phase and the oil phase were each dispersed and dissolved while being heated to 75 ° C. When the water part and the oil part were prepared, the mixture was mixed at 3000 rpm for 3 minutes using a homomixer at 75 ° C. Thereafter, tromethamine was added and neutralized using a homomixer at 3500 rpm for 3 minutes. The mixture was cooled to 45 ° C., and then added with additives. The mixture was dispersed evenly and stirred slowly while cooling.
구분division 성분(중량%)Ingredient (% by weight) 비교제형예1Comparative Formulation Example 1 비교제형예2Comparative Formulation Example 2 비교제형예3Comparative Formulation Example 3 제형예1Formulation Example 1 제형예2Formulation Example 2 제형예3Formulation Example 3 제형예4Formulation Example 4 제형예5Formulation Example 5
수상Awards 정제수Purified water To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100
방부제antiseptic 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity
글리세린glycerin 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
부틸렌글라이콜Butylene Glycol 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00
카보머Carbomer 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20
유상Paid 폴리소르베이트60Polysorbate 60 3.00 3.00 3.00 3.00 -  - 3.00 3.00 -  - -  - -  - -  -
소듐메틸스테아로일타우레이트Sodium methylstearoyl taurate -  - -  - 3.00 3.00 -  - 3.00 3.00 5.00 5.00 7.00 7.00 10.00 10.00
세테아릴알코올Cetearyl Alcohol 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00
카프릴릭/카프릭 트리글리세리드Caprylic / Capric Triglycerides 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
스쿠알란Squalane 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
사이클로펜타실록산Cyclopentasiloxane 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
마카다미아씨오일Macadamia Seed Oil 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
중화Chinese 트로메타민Tromethamine 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity
첨가adding 제조예 1의 글리세린 분산 식물프로토플라스트 구조체Glycerin dispersed plant protoplast structure of Preparation Example 1 10.0010.00 -- -- -- -- -- -- --
제조예 6의 오일 분산 식물 프로토플라스트 구조체Oil Dispersion Plant Protoplasm Structure of Preparation Example 6 -- 10.0010.00 10.0010.00 -- -- -- -- --
실시예 5의 마이크로캡슐Microcapsules of Example 5 -  - -  - -  - 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00 10.00
제형 내 식물프로토플라스트 구조체의 제조 직후 및 장기간 안정성을 확인하기 위해서 제조된 제형예 1 내지 5 및 비교제형예 1 내지 3의 화장료 조성물을 제조 직후 및 1개월 상온에서 보관 후 현미경(OLYMPUS BX51)을 통해 식물프로토플라스트 구조체의 안정도를 확인하고 그 결과를 표 5에 나타내었다. 이때 ◎은 "아주 좋음", ○는 "양호", △는 "약간 이상하나 실용상으로 문제가 없음", ×는 "불안정"을 의미한다.Immediately after the preparation of the phytoprotoplast structure in the formulation and for confirming long-term stability, the cosmetic compositions of Formulation Examples 1 to 5 and Comparative Formulation Examples 1 to 3 were prepared immediately and after storage for 1 month at room temperature. Through the confirmation of the stability of the plant protoplast structure and the results are shown in Table 5. ◎ is "very good", ○ is "good", △ is "slightly strange but practically no problem", × means "unstable".
구분division 제조 직후 안정도Stability immediately after manufacture 1개월 보관 후 안정도Stability after 1 month storage
비교제형예1Comparative Formulation Example 1 ×× ××
비교제형예2Comparative Formulation Example 2
비교제형예3Comparative Formulation Example 3 ××
제형예1Formulation Example 1
제형예2Formulation Example 2
제형예3Formulation Example 3
제형예4Formulation Example 4
제형예5Formulation Example 5
상기 표 5에 따르면, 제조예 1의 자사 개발된 글리세린에 분산된 식물 프로토플라스트 구조체를 포함하는 화장료 조성물 비교제형예 1은 비이온성 계면활성제 함유 제형에서 안정도가 좋지 않으며, 이를 개선하기 위해 개발되었던 제조예 6의 오일상에 분산된 식물 프로토플라스트 구조체를 포함하는 화장료 조성물 비교제형예 2 내지 3은 비이온성 계면활성제 함유 제형에서는 안정하지만 음이온성 계면활성제 함유 제형에서는 급격히 안정도가 저하되었다. 하지만 이를 마이크로캡슐로 봉입하여 안정화한 실시예 5를 포함하는 화장료 조성물인 제형예 1 내지 5의 경우 계면활성제 종류 및 함량에 관계없이 안정함을 확인하였다.According to Table 5, Comparative Composition Example 1 comprising a plant protoplast structure dispersed in its own glycerin of Preparation Example 1 is not stable in a non-ionic surfactant-containing formulation, was developed to improve Cosmetic composition comprising the plant protoplast structure dispersed in the oil phase of Preparation Example 6 Comparative Examples 2 to 3 is stable in nonionic surfactant-containing formulations, but rapidly decreased in anionic surfactant-containing formulations. However, in the case of the formulation examples 1 to 5, which is a cosmetic composition comprising Example 5 stabilized by encapsulating it in a microcapsule, it was confirmed that it is stable regardless of the type and content of the surfactant.
실험예Experimental Example 3: 물리적 힘에 따른 식물  3: plants by physical force 프로토플라스트Protoplasm 구조체 안정도 영향 Structure Stability Impact
제조 시 가해지는 물리적인 힘에 의한 식물 프로토플라스트 구조체의 안정도 영향을 알아보기 위하여 분산 방법을 달리하여 하기 표 6에 기재된 조성에 따라 비교제형예 4 내지 6 및 제형예 6 내지 9를 실시하였다.Comparative Formulation Examples 4 to 6 and Formulation Examples 6 to 9 were carried out in accordance with the composition shown in Table 6 by varying the dispersion method in order to determine the effect of stability of the plant protoplast structure by the physical force applied during manufacture.
먼저, 수상, 유상을 각각 75 ℃로 가온하며 분산, 용해시켰다. 수상 파트와 유상 파트가 준비되면 75 ℃에서 호모믹서를 이용하여 3분간 3000rpm으로 섞어주었다. 그 후 트로메타민을 넣어 3분간 3500rpm으로 호모믹서를 이용하여 중화하고 45℃로 냉각하여 첨가물을 넣어준 후 골고루 분산시켜준 후 냉각하면서 천천히 저어주었다. First, the aqueous phase and the oil phase were each dispersed and dissolved while being heated to 75 ° C. When the water part and the oil part were prepared, the mixture was mixed at 3000 rpm for 3 minutes using a homomixer at 75 ° C. Thereafter, tromethamine was added and neutralized using a homomixer at 3500 rpm for 3 minutes. The mixture was cooled to 45 ° C., and then added with additives. The mixture was dispersed evenly and stirred slowly while cooling.
첨가물을 넣어 준 뒤 분산 시, 패들/스크레이퍼 또는 호모 믹싱을 통해 분산 방법을 달리하였고 가해지는 물리적인 힘을 조절하였다.When the additives were added and dispersed, the dispersion method was changed by paddle / scraper or homo mixing and the physical force applied was adjusted.
구분division 성분(중량%)Ingredient (% by weight) 비교제형예 4Comparative Formulation Example 4 비교제형예 5Comparative Formulation Example 5 비교제형예 6Comparative Formulation Example 6 제형예6Formulation Example 6 제형예7Formulation Example 7 제형예8Formulation Example 8 제형예9Formulation Example 9
수상Awards 정제수Purified water To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100
방부제antiseptic 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity
글리세린glycerin 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
부틸렌글라이콜Butylene Glycol 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
카보머Carbomer 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20
유상Paid 글리세릴스테아레이트/피이지-100스테아레이트Glyceryl Stearate / Pig-100stearate 3.003.00 3.003.00 3.003.00 3.003.00 3.003.00 3.003.00 3.003.00
세테아릴알코올Cetearyl Alcohol 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00
망고버터Mango Butter 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00
카프릴릭/카프릭 트리글리세리드Caprylic / Capric Triglycerides 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
스쿠알란Squalane 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
사이클로펜타실록산Cyclopentasiloxane 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
마카다미아씨오일Macadamia Seed Oil 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00 5.005.00
중화Chinese 트로메타민Tromethamine 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity 적량Quantity
첨가adding 제조예 6의 오일 분산 식물프로토플라스트 구조체Oil-dispersed plant protoplast structure of Preparation Example 6 10.0010.00 10.0010.00 10.0010.00 -- -- -- --
실시예 5의 마이크로캡슐Microcapsules of Example 5 -- -- -- 10.0010.00 10.0010.00 10.0010.00 10.0010.00
분산 방법Dispersion method 호모 믹싱(Homo Mixing)Homo Mixing -- 1500rpm1500 rpm 3000rpm3000 rpm -- 1500rpm1500 rpm 3000rpm3000 rpm 6000rpm6000 rpm
패들/스크레이퍼 (Paddle/Scrapper Mixing)Paddle / Scrapper Mixing 20rpm20 rpm 20rpm20 rpm 20rpm20 rpm 20rpm20 rpm 20rpm20 rpm 20rpm20 rpm 20rpm20 rpm
제형 내 식물 프로토플라스트 구조체의 제조 직후 및 장기간 안정성을 확인하기 위해서 현미경(OLYMPUS BX51)을 통해 식물프로토플라스트 구조체의 안정도를 확인하였다. 그 결과는 아래 표 7에 나타내었다. 이때 ◎은 "아주 좋음", ○는 "양호", △는 "약간 이상하나 실용상으로 문제가 없음", ×는 "불안정"을 의미한다.The stability of the plant protoplast structure was confirmed through a microscope (OLYMPUS BX51) to confirm the long-term stability immediately after the preparation of the plant protoplast structure in the formulation. The results are shown in Table 7 below. ◎ is "very good", ○ is "good", △ is "slightly strange but practically no problem", × means "unstable".
구분division 제조 직후 안정도Stability immediately after manufacture 1개월 보관 후 안정도Stability after 1 month storage
비교제형예 4Comparative Formulation Example 4
비교제형예 5Comparative Formulation Example 5
비교제형예 6Comparative Formulation Example 6 ×× ××
제형예6Formulation Example 6
제형예7Formulation Example 7
제형예8Formulation Example 8
제형예9Formulation Example 9
상기 표 7에 따르면, 제조예 6의 종래 자사에서 개발하였던 오일에 분산된 식물프로토플라스트 구조체를 함유하는 비교제형예 4는 물리적으로 약한 힘을 가해서 제조 시 안정도에 큰 영향이 없으나 호모 믹싱(Homo mixing)을 통해 조금 강한 힘이 가해졌을 경우, 식물 프로토플라스트 구조체가 많이 파괴되었다. 하지만, 마이크로캡슐을 통해 안정화된 실시예 5를 적용한 제형예 6 내지 9의 경우, 제조 시 강한 물리적인 힘이 가해져도 구조체가 파괴되지 않고 잘 유지됨을 확인할 수 있었다. 이에 따라 식물 프로토플라스트 구조체를 마이크로캡슐로 봉입하여 안정화하면 저점도 유화 제형뿐만 아니라 고점도, 고경도 제품에도 다양하게 적용이 가능함을 확인하였다.According to Table 7, Comparative Example 4 containing a phytoprotoplast structure dispersed in the oil developed in the prior art of Preparation Example 6 does not significantly affect the stability during manufacturing by applying a weak physical force, but homo mixing (Homo When a little stronger force is applied through mixing, much of the plant protoplasm structure is destroyed. However, in the case of Formulation Examples 6 to 9 applying Example 5 stabilized through microcapsules, it was confirmed that the structure is well maintained without breaking even when a strong physical force is applied during manufacture. Accordingly, when the plant protoplast structure was encapsulated and stabilized by microcapsules, it was confirmed that the present invention can be applied to various products having high viscosity and high hardness as well as low viscosity emulsion formulation.
실험예Experimental Example 4: 피부 효능 평가 4: skin efficacy evaluation
30~50대 여성 10명을 대상으로 시험 시작 전 피부 수분량, 피부 밝기, 피부톤, 피부 거칠기, 피부 탄력 측정을 실시하였으며 측정은 피부 안정화를 위해 항온 항습실(온도 22 ± 2 ℃, 상대습도 40 ± 2 %)에서 30분 이상 적응 이후에 진행하였다.Ten women in their 30s to 50s were measured for skin moisture, skin brightness, skin tone, skin roughness, and skin elasticity before starting the test.The measurement was performed in a constant temperature and humidity room (temperature 22 ± 2 ℃, relative humidity 40 ± 2) to stabilize the skin. %) Progression after at least 30 minutes.
피험자들의 양쪽 뺨 부분을 시험부위로 지정하고 비교제형예 6과 제형예 9의 화장료 조성물을 양쪽 뺨에 각각 아침 저녁으로 2회씩 사용하게 하였으며, 사용 직후 및 사용 2, 4주 후에 측정 항목들에 대한 재측정을 실시하였다. Both cheeks of the subjects were designated as test sites, and the cosmetic compositions of Comparative Formulation Example 6 and Formulation Example 9 were used twice each morning and evening on both cheeks, and immediately after and 2 to 4 weeks after use, Remeasurement was performed.
4-1. 피부 보습효과4-1. Skin moisturizing effect
측정 기기는 피부의 수분 함량에 따른 피부의 전기 용량을 측정하여 보습력을 측정하는 수분 함량 측정기 (Corneometer CM825, Courage + Khazaka사, 독일)를 사용하였다. 그 결과는 하기 표 8에 나타내었다.The measuring device used a moisture content measuring instrument (Corneometer CM825, Courage + Khazaka, Germany) to measure the moisture capacity by measuring the electrical capacity of the skin according to the moisture content of the skin. The results are shown in Table 8 below.
구분division 도포 전 피부 수분량Skin moisture before application 4주 후 피부 수분량Skin moisture after 4 weeks 개선율(%)% Improvement
제형예 9Formulation Example 9 50.4050.40 55.5455.54 25.6025.60
비교제형예6Comparative Formulation Example 6 50.0850.08 51.5451.54 2.922.92
4-2. 피부 탄력효과4-2. Skin elasticity effect
음압을 이용한 측정장비는 피부를 흡입과 흡입시간의 지속에 따른 피부 변화와 복원력을 기본 원리로 하여 측정하는 방식으로 기기 내부에 마이너스 압력을 주어 피부를 빠르고 균일하게 흡입하여 측정 부위의 피부 변화값을 광학 측정 시스템이 인지하여 수치가 변화하는 원리로 탄력 값이 높을수록 탄력이 좋을 것으로 평가한다. 대표적인 장비로, Cutometer MPA 580(Courage+Khazaka)는 지속적인 음압으로 측정시간 동안 프로브 속으로 피부가 빨려 들어간 뒤, 음악이 제거되면서 피부 원래의 모습으로 돌아가는 원리를 이용하여 피부탄력을 측정한다. 기기에 연결된 2mm 직경의 프로브를 피부에 밀착시키고 비침습적인 방법으로 측정하며, 측정단위는 임의의 단위 (Arbitrary Unit, A.U.)이다. 그 결과는 도 2에 나타내었다. Negative pressure measurement equipment measures skin on the basis of skin change and restorative force according to the inhalation and duration of inhalation time. The higher the elasticity value is, the better the elasticity is. As a representative instrument, Cutometer MPA 580 (Courage + Khazaka) measures skin elasticity using the principle that the skin is sucked into the probe during the measurement time with continuous sound pressure, and then the music is removed and the skin is returned to its original appearance. A 2 mm diameter probe connected to the instrument is placed in close contact with the skin and measured in a non-invasive way. The unit of measurement is Arbitrary Unit (A.U.). The results are shown in FIG.
4-3. 4-3. 피부밝기Skin brightness
피부 밝기는 페이셜 스테이지(Facial Stage)를 이용하여 얼굴의 전체를 촬영한다. 그 결과는 도 3에 나타내었다. Skin brightness is taken on the entire face using the Facial Stage (Facial Stage). The results are shown in FIG.
4-4. 피부 윤기4-4. Skin glow
피부 정반사광은 CD-2500d(minolta, Japan)를 이용하여 측정하였다. 이때 CD-2500d는 기존의 분광측색계와는 달리 2개의 펄스제논램프(pulsed xenon arc lamp)를 통해 SCI와 SCE를 동시에 측정하여 1.5초 이내에 액정에 표시해 준다. Skin specular light was measured using CD-2500d (minolta, Japan). At this time, unlike the existing spectrophotometer, the CD-2500d simultaneously measures SCI and SCE through two pulsed xenon arc lamps and displays them on the liquid crystal within 1.5 seconds.
얼굴의 뺨 부분에 해당하는 L*(SCI, SCE)를 3회씩 측정하였으며 측정치의 평균을 구하였다. 그리고 SCI값에서 SCE값을 뺀 차이를 계산하였다. 그 결과는 도 4에 나타내었다.The L * (SCI, SCE) corresponding to the cheek area of the face was measured three times and averaged. And SCI value was calculated by subtracting the SCE value. The results are shown in FIG.
도 1 내지 4를 참조하면, 본 발명에 따른 마이크로캡슐을 함유한 제형이 식물 프로토플라스트 구조체 자체를 함유한 제형 보다 피부 보습, 피부 탄력, 피부 밝기 및 피부 윤기 개선 효과가 더 우수한 것으로 나타났다. 이는 마이크로캡슐의 벽제를 형성하는 레시틴이 피부 도포 시 식물 프로토플라스트 구조체의 피부 흡수를 개선하기 때문인 것으로 생각된다.1 to 4, it was shown that the formulation containing the microcapsules according to the present invention has better skin moisturizing, skin elasticity, skin brightness and skin gloss improvement effects than the formulation containing the plant protoplast structure itself. This is believed to be because lecithin, which forms the walls of the microcapsules, improves skin absorption of the plant protoplast structure upon skin application.
이하, 본 발명의 이해를 돕기 위하여 바람직한 제형예를 제시한다. 그러나 하기의 제형예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 제형예에 의해 본 발명의 내용이 한정되는 것은 아니다.Hereinafter, preferred formulation examples are provided to aid the understanding of the present invention. However, the following formulation examples are merely provided to more easily understand the present invention, and the contents of the present invention are not limited by the formulation examples.
제형예Formulation example 1: 영양 크림의 제조 1: Preparation of Nutritional Cream
하기의 표 9와 같은 조성을 갖도록 공지 방법을 이용하여 영양 크림을 제조하였다.To prepare a nutritious cream using a known method to have a composition as shown in Table 9 below.
성분ingredient 함량(중량%)Content (% by weight)
실시예 5의 마이크로캡슐Microcapsules of Example 5 0.50.5
친유형 모노스테아린산글리세린Lipophilic monostearate 2.02.0
세테아릴알콜Cetearyl Alcohol 2.02.0
스테아린산Stearic acid 1.51.5
폴리솔베이트 60Polysorbate 60 1.51.5
솔비탄스테아레이트Sorbitan stearate 0.60.6
하이드로제네이티드 폴리이소부텐Hydrogenated Polyisobutene 1.01.0
스쿠알란Squalane 3.03.0
광물유Mineral oil 5.05.0
사이클로메치콘Cyclomethicone 5.05.0
디메치콘Dimethicone 1.01.0
초산토코페롤Tocopherol Acetate 0.50.5
글리세린glycerin 5.05.0
베타인Betaine 3.03.0
트리에탄올아민Triethanolamine 1.01.0
산탄검Xanthan Gum 0.050.05
incense 적량Quantity
방부제antiseptic 적량Quantity
색소Pigment 적량Quantity
증류수Distilled water 잔량Remaining amount
합계Sum 100.00100.00
제형예Formulation example 2: 유연 화장수(스킨로션)의 제조 2: Preparation of flexible lotion (skin lotion)
하기의 표 10과 같은 조성을 갖도록 공지 방법을 이용하여 유연 화장수를 제조하였다.A flexible lotion was prepared using a known method to have a composition as shown in Table 10 below.
성분ingredient 함량(중량%)Content (% by weight)
실시예 5의 마이크로캡슐Microcapsules of Example 5 0.30.3
글리세린glycerin 5.05.0
1,3-부틸렌글리콜1,3-butylene glycol 3.03.0
베타인Betaine 1.01.0
알란토인Allantoin 0.10.1
DL-판테놀DL-panthenol 0.30.3
EDTA-2NaEDTA-2Na 0.020.02
소듐 히아루로네이트 파우더Sodium hyaluronate powder 0.050.05
에탄올ethanol 5.05.0
옥틸도데세스-16Octyldodeceth-16 0.20.2
폴리옥시에칠렌경화피마자유Polyoxyethylene Cured Castor Oil 0.20.2
incense 적량Quantity
방부제antiseptic 적량Quantity
색소Pigment 적량Quantity
정제수Purified water 잔량Remaining amount
합계Sum 100.00100.00
제형예Formulation example 3 : 영양 화장수 3: nutrition lotion
하기의 표 11과 같은 조성을 갖도록 공지 방법을 이용하여 영양 화장수를 제조하였다.To prepare a nutritional lotion using a known method to have a composition as shown in Table 11.
성분ingredient 함량(중량%)Content (% by weight)
실시예 5의 구조체 혼합물Structure Mixture of Example 5 0.50.5
글리세릴 스테아레이트 SEGlyceryl Stearate SE 1.51.5
세테아릴알콜Cetearyl Alcohol 1.01.0
쉐어버터Shea Butter 1.51.5
폴리솔베이트 60Polysorbate 60 1.31.3
솔비탄스테아레이트Sorbitan stearate 0.50.5
경화식물유Cured Vegetable Oil 1.01.0
광물유Mineral oil 5.05.0
스쿠알란Squalane 3.03.0
사이클로메치콘Cyclomethicone 2.02.0
디메치콘Dimethicone 0.80.8
초산 토코페롤Tocopherol Acetate 0.50.5
카보머Carbomer 0.120.12
글리세린glycerin 5.05.0
1,3-부틸렌글리콜1,3-butylene glycol 3.03.0
소듐 히아루로네이트 파우더Sodium hyaluronate powder 0.050.05
트리에탄올아민Triethanolamine 0.120.12
incense 적량Quantity
방부제antiseptic 적량Quantity
색소Pigment 적량Quantity
증류수Distilled water 잔량Remaining amount
합계Sum 100.00100.00
제형예Formulation example 4 :  4 : 맛사지Massage 크림 cream
하기의 표 12와 같은 조성을 갖도록 공지 방법을 이용하여 맛사지 크림을 제조하였다.Massage cream was prepared using a known method to have a composition as shown in Table 12 below.
성분ingredient 함량(중량%)Content (% by weight)
실시예 5의 마이크로캡슐Microcapsules of Example 5 0.50.5
친유형 모노스테아린산 글리세린Lipophilic Monostearic Acid Glycerin 1.51.5
세테아릴알콜Cetearyl Alcohol 1.51.5
스테아린산Stearic acid 1.01.0
폴리솔베이트 60Polysorbate 60 1.51.5
솔비탄스테아레이트Sorbitan stearate 0.60.6
이소스테아릴 이소스테레이트Isostearyl Isosterate 5.05.0
스쿠알란Squalane 5.05.0
광물유Mineral oil 3535
디메치콘Dimethicone 0.50.5
히드록시에틸셀룰로오스Hydroxyethyl cellulose 0.120.12
글리세린glycerin 6.06.0
1,3-부틸렌글리콜1,3-butylene glycol 3.03.0
트리에탄올아민Triethanolamine 0.30.3
incense 적량Quantity
방부제antiseptic 적량Quantity
색소Pigment 적량Quantity
증류수Distilled water 잔량Remaining amount
합계Sum 100.00100.00
제형예Formulation example 5 : 에센스 5: essence
하기의 표 13과 같은 조성을 갖도록 공지 방법을 이용하여 에센스를 제조하였다.Essence was prepared using a known method to have a composition as shown in Table 13.
성분ingredient 함량(중량%)Content (% by weight)
실시예 5의 마이크로캡슐Microcapsules of Example 5 0.50.5
글리세린glycerin 6.06.0
베타인Betaine 5.05.0
PEG 1500PEG 1500 2.02.0
알란토인Allantoin 0.10.1
DL-판테놀DL-panthenol 0.30.3
EDTA-2NaEDTA-2Na 0.020.02
하이드로제네이티드 레시친Hydrogenated Lecithin 0.60.6
히드록시에틸 셀룰로오스Hydroxyethyl cellulose 0.10.1
소듐 히아루로네이트 파우더Sodium hyaluronate powder 0.080.08
카르복시비닐폴리머Carboxy Vinyl Polymer 0.20.2
트리에탄올아민Triethanolamine 0.20.2
세라마이드Ceramide 0.20.2
옥틸도데칸올Octyldodecanol 3.03.0
스쿠알란Squalane 3.03.0
폴리소르베이트 60Polysorbate 60 0.40.4
글리세릴 스테아레이트 SEGlyceryl Stearate SE 1.51.5
incense 적량Quantity
방부제antiseptic 적량Quantity
색소Pigment 적량Quantity
증류수Distilled water 잔량Remaining amount
합계Sum 100.00100.00
제형예Formulation example 6 : 팩 6: pack
하기의 표 14와 같은 조성을 갖도록 공지 방법을 이용하여 팩을 제조하였다.To prepare a pack using a known method to have a composition as shown in Table 14.
성분ingredient 함량(중량%)Content (% by weight)
실시예 5의 마이크로캡슐Microcapsules of Example 5 0.50.5
폴리비닐알콜Polyvinyl alcohol 1515
셀룰로오스 검Cellulose gum 0.150.15
글리세린glycerin 3.03.0
PEG 1500PEG 1500 2.02.0
베타인Betaine 2.02.0
DL-판테놀DL-panthenol 0.40.4
알란토인Allantoin 0.10.1
트리에탄올아민Triethanolamine 0.20.2
니코틴아미드Nicotinamide 0.50.5
에탄올ethanol 6.06.0
PEG 40 경화피마자유PEG 40 Cured Castor Oil 0.30.3
incense 적량Quantity
방부제antiseptic 적량Quantity
색소Pigment 적량Quantity
증류수Distilled water 잔량Remaining amount
합계Sum 100.00100.00

Claims (9)

  1. 탈분화 식물 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체를 포함하는 코어와,A core comprising a structure having an active substance introduced therein into a dedifferentiated plant protoplast,
    상기 코어를 둘러싸도록 형성되며, 콜라겐, 아카시아 검, 레시틴 및 가교제를 포함하는 쉘A shell formed surrounding the core and comprising collagen, acacia gum, lecithin and a crosslinking agent
    을 포함하는 마이크로캡슐. Microcapsules comprising a.
  2. 제1항에 있어서, 상기 식물은 The method of claim 1, wherein the plant
    커리플랜트(curry plant, Helichrysum italicum), 구갈(Commiphora wightii , Commiphora myrrha), 부채 선인장(Opuntia Ficus indica), 작약(Paeonia lactiflora), 석화(Adenium obesum), 님파이아 오도라타(Nymphaea coerulea), 유칼리투스(Eucalyptus punctata), 은행나무(Ginkgo biloba), 나리꽃(Lilium candidum), 감람나무(Olea europaea), 파피루스(Cyperus papyrus), 연꽃(Nelumbo nucifera), 레드우드(Sequoia sempervirens), 가리카 로즈(Rosa gallica officinalis), 커피나무(Coffea arabica), 플루메리아(Plumeria obtusa), 치자나무(Gardenia jasminoides), 부겐베리아(Bougainvillea spectabilis), 자스민(Jasminum sambac), 로사 센티폴리아(Rosa centifolia), 페퍼민트(Mentha piperita), 로사 다마스케나(Rosa damascena), 붓꽃(Iris pallida), 포도나무(Vitis vinifera), 백장미(Rosa alba), 일랑일랑(Cananga odorata), 아몬드 나무(Prunus amygdalus dulcis), 사과나무(Malus domestica), 살구나무(Prunus armeniaca), 인삼(Panax ginseng), 블랙베리(Rubus fruticosus), 금영화(Eschscholtzia californica), 병풀(Centella asiatica), 신양벚나무(Prunus cerasus), 하와이 무궁화(Hibiscus rosa sinensis), 주니퍼베리(Juniperus communis), 목화(Gossypium arboreum), 대추야자(Phoenix dactylifera), 생강(Zingiber officinale), 무궁화(Hibiscus syriacus), 푸에라리아투베로사(Pueraria tuberosa), 석류나무(Punica granatum), 붐박스 코스타튬(Bombax costatum), 사프란(Crocus sativus), 살비아(Salvia officinalis), 수련(Nymphaea alba) 및 이들의 조합으로 이루어진 군에서 선택된 1종인 것을 특징으로 하는 마이크로캡슐.Curry Plant ( Helichrysum italicum ), comiphora wightii , Commiphora myrrha ), Opuntia Ficus indica ), Peony ( Paeonia lactiflora ), Petrifying ( Adenium) obesum ), Nymphaea Odorata coerulea), eucalyptus Tooth (Eucalyptus punctata), ginkgo (Ginkgo biloba), lilies (Lilium candidum), the olive tree (Olea europaea ), papyrus ( Cyperus papyrus ), lotus ( Nelumbo nucifera ), redwood ( Sequoia sempervirens ), roca rose (R osa gallica officinalis ), coffee tree ( Coffea arabica , Plumeria obtusa , Gardenia jasminoides , Bougainvillea spectabilis , Jasminum sambac , Rosa centifolia , Peppermint, Rosa damascena , Rosa damascena , Iris pallida , Vitis vinifera , Rosa alba , Cananga odorata ), almond tree ( Prunus amygdalus) dulcis ), apple tree ( Malus domestica ), Apricot ( Prunus armeniaca ), Ginseng ( Panax ginseng ), Blackberry ( Rubus fruticosus ), gold film ( Eschscholtzia californica ), Centella ( Centella asiatica ), Prunus cerasus , Hibiscus rosa sinensis , Hawaiian Juniperus communis , Gossypium arboreum ), date palm ( Phoenix dactylifera ), ginger ( Zingiber officinale ), rose of sharon ( Hibiscus syriacus ), Pueraria tuberosa , pomegranate (Punica granatum), boombox costatum , saffron ( Crocus sativus ), Salvia ( Salvia officinalis ), water lily ( Nymphaea alba ) and microcapsules characterized in that one selected from the group consisting of a combination thereof.
  3. 제1항에 있어서, 상기 활성 물질은 친수성 물질 및 소수성 물질로 이루어진 군에서 선택된 1종인 것을 특징으로 하는 마이크로캡슐.The microcapsule according to claim 1, wherein the active substance is one selected from the group consisting of hydrophilic substances and hydrophobic substances.
  4. 제1항에 있어서, 상기 활성 물질은 유기산, 비타민, 알부틴, 아데노신, 나이아신아마이드, 폴리페놀, 플라보노이드, 레티놀, 사이클로헥산다이올 비스에틸헥사노에이트, 비스레틴아미도 메틸펜탄, 베타라파촌, 성장인자, 성장인자 복합 펩타이드, 및 이들의 조합으로 이루어진 군에서 선택된 1종인 것을 특징으로 하는 마이크로캡슐.The method of claim 1, wherein the active substance is an organic acid, vitamin, arbutin, adenosine, niacinamide, polyphenol, flavonoid, retinol, cyclohexanediol bisethylhexanoate, bisretinamido methylpentane, betarapan, growth Microcapsule, characterized in that the one selected from the group consisting of factors, growth factor complex peptide, and combinations thereof.
  5. 제1항에 있어서, 상기 활성 물질의 인입률은 0.001∼20 중량%인 것을 특징으로 하는 마이크로캡슐.The microcapsule according to claim 1, wherein the active material has a content rate of 0.001 to 20% by weight.
  6. 제1항에 있어서, 상기 코어는The method of claim 1, wherein the core is
    올리브 오일, 해바라기씨 오일, 메도우폼씨 오일, 아르간 오일, 아보카도 오일, 밀배아오일, 로즈힙 오일, 아몬드 오일, 피마자유, 동백오일, 옥수수오일, 잇꽃 오일, 대두오일, 유채꽃 오일, 마카나디아넛츠 오일, 호호바 오일, 팜오일, 팜핵오일, 코코넛 오일, 망고버터 오일, 쉐어버터 오일, 코코아수씨드 버터 오일, 정제포도씨 오일, 로즈힙 오일, 사플라워 오일 및 복숭아씨 오일로 이루어진 군에서 선택된 1종의 식물성 오일을 더욱 포함하는 것을 특징으로 하는 마이크로캡슐.Olive Oil, Sunflower Seed Oil, Meadowfoam Seed Oil, Argan Oil, Avocado Oil, Wheat Germ Oil, Rose Hip Oil, Almond Oil, Castor Oil, Camellia Oil, Corn Oil, Safflower Oil, Soybean Oil, Rapeseed Oil, Maca Nut Nuts 1 type selected from the group consisting of oil, jojoba oil, palm oil, palm kernel oil, coconut oil, mango butter oil, shea butter oil, cocoa seed butter oil, refined grape seed oil, rosehip oil, saffron oil and peach seed oil Microcapsules further comprising a vegetable oil.
  7. 제6항에 있어서, 상기 코어는The method of claim 6, wherein the core is
    탈분화 식물 프로토플라스트(protoplast) 내에 활성 물질이 인입된 구조체와 식물성 오일이 1:9 내지 5:5의 중량비로 혼합되어 있는 것을 특징으로 하는 마이크로캡슐.A microcapsule, characterized in that the structure in which the active substance is introduced into the dedifferentiated plant protoplast and the vegetable oil are mixed in a weight ratio of 1: 9 to 5: 5.
  8. 제1항에 있어서, 상기 마이크로캡슐은The method of claim 1, wherein the microcapsules
    입자 크기가 10~100 ㎛인 것을 특징으로 하는 마이크로캡슐.Microcapsules, characterized in that the particle size is 10 ~ 100 ㎛.
  9. 제1항 내지 제8항 중 어느 한 항에 따른 마이크로캡슐을 함유하는 화장료 조성물.Cosmetic composition containing the microcapsules according to any one of claims 1 to 8.
PCT/KR2015/012038 2015-03-02 2015-11-10 Microcapsule containing structure in which active material is inserted into de-differentiated plant protoplast, and cosmetic composition containing same WO2016140421A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0028908 2015-03-02
KR1020150028908A KR102268533B1 (en) 2015-03-02 2015-03-02 Microcapsules Containing Dedifferentiated Plant Protoplast Complex With Active Material Insertion and Cosmetic Composition Comprising the Microcapsules

Publications (1)

Publication Number Publication Date
WO2016140421A1 true WO2016140421A1 (en) 2016-09-09

Family

ID=56848097

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/012038 WO2016140421A1 (en) 2015-03-02 2015-11-10 Microcapsule containing structure in which active material is inserted into de-differentiated plant protoplast, and cosmetic composition containing same

Country Status (2)

Country Link
KR (1) KR102268533B1 (en)
WO (1) WO2016140421A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108085292A (en) * 2017-12-04 2018-05-29 湖北省农业科学院果树茶叶研究所 A kind of isolation and purification method of tea tree mesophyll protoplast
CN109846784A (en) * 2019-03-13 2019-06-07 广州莱倩化妆品有限公司 A kind of formula and preparation method thereof of elasticity muffin
CN112655967A (en) * 2020-12-16 2021-04-16 黑龙江省林业科学院伊春分院 Artemisia sphaerocephala essential oil microcapsule taking purslane extract as wall material and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112143769B (en) * 2020-09-29 2022-09-06 杨凌萃健生物工程技术有限公司 A method for preparing radix Puerariae polypeptide extract from radix Puerariae residue and radix Puerariae polypeptide extract prepared thereby

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050265953A1 (en) * 2002-03-20 2005-12-01 Rachid Ennamany Method of obtaining phytoalexins
KR100637342B1 (en) * 2003-10-30 2006-10-23 윤성용 Use of a callus for development of natural cosmetics
KR20120006722A (en) * 2010-07-13 2012-01-19 웅진코웨이주식회사 Cosmetic composition comprising double-shell nano-structure
KR20120139137A (en) * 2011-06-16 2012-12-27 (주)아모레퍼시픽 Active material stabilized in plant cell and method for manufacturing the same
WO2013102882A2 (en) * 2012-01-05 2013-07-11 L'oreal Cosmetic use of dedifferentiated plant cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864446B1 (en) 2003-12-29 2006-03-03 Secma Biotechnologies Marines USE IN A COSMETIC OR PHARMACEUTICAL COMPOSITION OF AT LEAST ONE LYIPHILISATE OF DIFFERENTIATED VEGETABLE CELLS FOR DEPIGMENTING AND / OR LIGHTENING, PROTECTING AND REGENERATING EPIDERMA
WO2012102456A1 (en) 2011-01-26 2012-08-02 주식회사 코스메카코리아 Cosmetic composition for reducing wrinkles containing euphorbia supina extracts
WO2013180526A1 (en) 2012-05-31 2013-12-05 (주)아모레퍼시픽 Skin regeneration and hair growth promoter containing edelweiss extract

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050265953A1 (en) * 2002-03-20 2005-12-01 Rachid Ennamany Method of obtaining phytoalexins
KR100637342B1 (en) * 2003-10-30 2006-10-23 윤성용 Use of a callus for development of natural cosmetics
KR20120006722A (en) * 2010-07-13 2012-01-19 웅진코웨이주식회사 Cosmetic composition comprising double-shell nano-structure
KR20120139137A (en) * 2011-06-16 2012-12-27 (주)아모레퍼시픽 Active material stabilized in plant cell and method for manufacturing the same
WO2013102882A2 (en) * 2012-01-05 2013-07-11 L'oreal Cosmetic use of dedifferentiated plant cells

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108085292A (en) * 2017-12-04 2018-05-29 湖北省农业科学院果树茶叶研究所 A kind of isolation and purification method of tea tree mesophyll protoplast
CN109846784A (en) * 2019-03-13 2019-06-07 广州莱倩化妆品有限公司 A kind of formula and preparation method thereof of elasticity muffin
CN112655967A (en) * 2020-12-16 2021-04-16 黑龙江省林业科学院伊春分院 Artemisia sphaerocephala essential oil microcapsule taking purslane extract as wall material and preparation method thereof

Also Published As

Publication number Publication date
KR20160106268A (en) 2016-09-12
KR102268533B1 (en) 2021-06-23

Similar Documents

Publication Publication Date Title
WO2015099274A1 (en) Structure in which active material is inserted into de-differentiated plant protoplast, method for preparing same, and cosmetic composition containing same
WO2016140421A1 (en) Microcapsule containing structure in which active material is inserted into de-differentiated plant protoplast, and cosmetic composition containing same
US20130108567A1 (en) Skin-whitening composition for external application on skin containing extracts from paper mulberry flowers and fruits
WO2012070804A2 (en) Cosmetic composition containing an oleanolic acid
WO2010064878A2 (en) Anti-wrinkle cosmetic skin composition containing leontopodic acid as an active ingredient
KR102473093B1 (en) Cosmetic composition for improving skin condition comprising hemp seed oil, plant callus culture filtrate and peptides as active ingredient
KR102243502B1 (en) Stabilization Method of Dedifferentiated Plant Protoplast Complex With Active Material Insertion
KR100824212B1 (en) Composition for skin protection containing placenta and preparation method thereof
KR20110057954A (en) Anti-oxidant or anti-aging cosmetic composition
WO2022085858A1 (en) Composition for whitening skin or ameliorating wrinkles comprising dendropanax morbiferus extract
KR101325553B1 (en) Cosmetic Composition for Protecting Skin Comprising Aminolevulinic acid Contained in Liquid Crystal Base
KR20090009054A (en) Cosmetic composition comprising nanovesicle vitatox which having the effect of anti-oxidation and the effect of anti- wrinkle around the eye
KR20190068363A (en) Cosmetic composition for skin Humectant comprising Opuntia Ficus-Indica fruit extract and mixed compound of panthenol, hyaluronic acid and betaine
KR20100067802A (en) Skin whitening cosmetic composition containing broussonetia extract stabilized with nano-liposome
WO2019151800A1 (en) Cosmetic composition for generating hydrogen and method for generating hydrogen by using same
WO2021095966A1 (en) Skin-whitening cosmetics composition containing chlorella extract as active ingredient
KR100570092B1 (en) Cosmetic Composition for Protecting Skin Comprising Plant Extract Stabilized in Nanoliposome
KR102283326B1 (en) Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment
KR100439939B1 (en) ANTIAGING COSMETIC COMPOSITIONS CONTAINING elm's root skin, ULMUS DAVIDIANA
KR101969684B1 (en) A cosmetic composition for anti-wrinkle and skin pore reduction containing natural spicule powder and natural complex extract
KR101987420B1 (en) Cosmetic composition for skin moisturizing and skin soothing comprising dioscorea villosa, sesame indicum, saussurea involucrata and lonicera japonica extract
WO2023239136A1 (en) Oleosome preparation composition with excellent stability and antimicrobial activity comprising branched diol-based compound as active ingredient and method for preparing same
KR101763736B1 (en) Composition for moisturizing skin containing extracts prepared by enzyme process
WO2015005700A1 (en) Composition for promoting hair sprouting and hair growth
US7303774B2 (en) Relax cosmetic having a temperature effect

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15884087

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15884087

Country of ref document: EP

Kind code of ref document: A1